<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">91864</article-id>
<article-id pub-id-type="doi">10.7554/eLife.91864</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.91864.2</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.2</article-version>
</article-version-alternatives>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Developmental Biology</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Inhibition of the serine protease HtrA1 by SerpinE2 suggests an extracellular proteolytic pathway in the control of neural crest migration</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0625-0006</contrib-id>
<name>
<surname>Pera</surname>
<given-names>Edgar M.</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moura</surname>
<given-names>Josefine Nilsson-De</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1412-7403</contrib-id>
<name>
<surname>Pomeshchik</surname>
<given-names>Yuriy</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="author-notes" rid="n1">#</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5532-4964</contrib-id>
<name>
<surname>Roybon</surname>
<given-names>Laurent</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="author-notes" rid="n1">#</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Milas</surname>
<given-names>Ivana</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<aff id="a1"><label>1</label><institution>Vertebrate Developmental Biology Laboratory, Department of Laboratory Medicine, Lund Stem Cell Center, University of Lund</institution>, 22184 Lund, <country>Sweden</country></aff>
<aff id="a2"><label>2</label><institution>iPSC Laboratory for CNS Disease Modeling, Department of Experimental Medical Science, Lund Stem Cell Center, Strategic Research Area MultiPark, Lund University</institution>, 22184 Lund, <country>Sweden</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Mishina</surname>
<given-names>Yuji</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>University of Michigan</institution>
</institution-wrap>
<city>Ann Arbor</city>
<country>United States of America</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Cooper</surname>
<given-names>Jonathan A</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution>Fred Hutchinson Cancer Research Center</institution>
</institution-wrap>
<city>Seattle</city>
<country>United States of America</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>Address correspondence to: Edgar Pera. Lund Stem Cell Center, University of Lund, BMC, D10, Klinikgatan 32, 22184 Lund, Sweden. Email: <email>edgar.pera@med.lu.se</email></corresp>
<fn id="n1" fn-type="others"><label>#</label><p>Department of Neurodegenerative Science, The MiND program, Van Andel Institute, Grand Rapids, MI, USA.</p></fn>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2023-10-11">
<day>11</day>
<month>10</month>
<year>2023</year>
</pub-date>
<pub-date date-type="update" iso-8601-date="2024-04-05">
<day>05</day>
<month>04</month>
<year>2024</year>
</pub-date>
<volume>12</volume>
<elocation-id>RP91864</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2023-09-01">
<day>01</day>
<month>09</month>
<year>2023</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2023-09-05">
<day>05</day>
<month>09</month>
<year>2023</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.09.05.556243"/>
</event>
<event>
<event-desc>Reviewed preprint v1</event-desc>
<date date-type="reviewed-preprint" iso-8601-date="2023-10-11">
<day>11</day>
<month>10</month>
<year>2023</year>
</date>
<self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.91864.1"/>
<self-uri content-type="editor-report" xlink:href="https://doi.org/10.7554/eLife.91864.1.sa2">eLife assessment</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.91864.1.sa1">Reviewer #1 (Public Review):</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.91864.1.sa0">Reviewer #2 (Public Review):</self-uri>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2023, Pera et al</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Pera et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-91864-v2.pdf"/>
<abstract>
<title>Abstract</title><p>We previously showed that SerpinE2 and the serine protease HtrA1 modulate fibroblast growth factor (FGF) signaling in germ layer specification and head-to-tail development of <italic>Xenopus</italic> embryos. Here we present an extracellular proteolytic mechanism involving this serpin-protease system in the developing neural crest (NC). Knockdown of SerpinE2 by injected antisense morpholino oligonucleotides did not affect the specification of NC progenitors but instead inhibited the migration of NC cells, causing defects in dorsal fin, melanocyte and craniofacial cartilage formation. Similarly, overexpression of the HtrA1 protease impaired NC cell migration and the formation of NC-derived structures. The phenotype of SerpinE2 knockdown was overcome by concomitant downregulation of HtrA1, indicating that SerpinE2 stimulates NC migration by inhibiting endogenous HtrA1 activity. SerpinE2 binds to HtrA1, and the HtrA1 protease triggers degradation of the cell surface proteoglycan Syndecan-4 (Sdc4). Microinjection of <italic>Sdc4</italic> mRNA partially rescued NC migration defects induced both by HtrA1 upregulation and SerpinE2 downregulation. These epistatic experiments suggest a proteolytic pathway by a double inhibition mechanism:
<disp-quote><p>SerpinE2 ┤HtrA1 protease ┤Syndecan-4 → NC cell migration</p></disp-quote></p>
</abstract>

</article-meta>
<notes>
<notes notes-type="competing-interest-statement">
<title>Competing Interest Statement</title><p>The authors have declared no competing interest.</p></notes>
<fn-group content-type="summary-of-updates">
<title>Summary of Updates:</title>
<fn fn-type="update"><p>Abstract updated to highlight the link of the Serpin-HtrA1 axis to FGF signaling.
Introduction revised to remove extensive descriptions of cancer and indicate the effects of HtrA1 and SerpinE2 on FGF/Erk signaling and Brachyury expression.
Section on Results updated to describe new experimental data for HtrA1 and SerpinE2 in the formation of the head cartilage skeleton.
Results section revised to describe the validation of morpholinos (MOs) and to more clearly present the plasmid constructs, their validation in biochemical assays and their phenotypic effects in Xenopus embryos.
Discussion revised to shorten the paragraphs on placenta development and cancer. A new sub-section added to discuss a possible link of the SerpinE2/HtrA1 pair and FGF signals in neural crest migration.
Material and Methods updated with a Key Resources Table, protocols for transfection and Western blotting.
Figures 2-4, 6 updated to highlight striking phenotypes with red frames.
Figures 2,3,5-8 revised to introduce a uniform labeling system with filled and open arrowheads for normal and defective structures.
Figure 4 revised to present new whole-mount in situ hybridization data with the chondrogenic marker Sox9 in uninjected early tadpoles and sibling embryos after microinjection of HtrA1 mRNA, control-MO, and SerpinE2-MO.
Figure 4L revised to indicate all cartilage structures jointly with their origin from neural crest streams.
Figure 4, figure supplement 2D revised to show that one-way ANOVA followed by Tukeys post hoc test was used for multiple comparisons.
Figure 5F,L revised to clarify that unpaired t-test was employed for comparing two treatment groups.
Two new time-lapse movies added to show collective migration of cranial neural crest cells in culture (Figure 5-video 1) and failure of these cells to adhere to fibronectin upon SerpinE2 depletion (Figure 5-video 2).
Figure 6-figure supplement 2 revised to show unedited Western blots for transfected HEK293T cells. In a previous version of blots for Ponceau Red (cell lysate, B) and anti-flag (supernatant, C), the contrast and brightness of the entire images (i.e. not individual lanes) were modified. Figure legend updated to clarify that Flag-HtrA1 and Flag-SerpinE2 have an apparent molecular weight expected for secretory glycoproteins, and that low levels of signal peptide-deficient proteins are likely due to cell lysis. Three source data files are added to show uncropped gels and membranes.
Figure 9B revised to indicate a chemotactic gradient of FGF signals, the source of FGF ligands in target cells and FGF receptors on cells of the neural crest collective.
</p></fn>
</fn-group>
</notes>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Collective cell migration is a fundamental process in the development and maintenance of multicellular organisms (<xref ref-type="bibr" rid="c17">Friedl and Gilmour, 2009</xref>; <xref ref-type="bibr" rid="c60">Shellard and Mayor, 2020</xref>). Embryonic development relies on the coordinated movement of cells to specific locations, and aberrant cell migration is linked to cancer metastasis. The acquisition of cell motility is associated with an epithelial-mesenchymal transition (EMT), in which cells disrupt epithelial adhesions and remodel junctional complexes in favor of cell-matrix adhesions to adopt a migratory behavior (<xref ref-type="bibr" rid="c43">Nieto et al., 2016</xref>; <xref ref-type="bibr" rid="c51">Piacentino et al., 2020</xref>). The EMT does not have to be complete, and cells can be motile whilst maintaining contact with one another. A prime example for the study of collective cell migration is the neural crest (NC) in vertebrate embryos (<xref ref-type="bibr" rid="c65">Szabó and Mayor, 2018</xref>). The NC is a multipotent cell population that is specified at the border of the neural plate (<xref ref-type="bibr" rid="c31">Le Douarin and Kalcheim, 1999</xref>; <xref ref-type="bibr" rid="c57">Schock et al., 2023</xref>). EMT initiates migration streams of NC cells towards their targets where they differentiate into diverse cell types and tissues, including peripheral nervous system, melanocytes and craniofacial skeleton. The behavior of NC cells recapitulates certain stages of cancer progression and metastasis (<xref ref-type="bibr" rid="c43">Nieto et al., 2016</xref>). Defects in NC development can lead to many congenital syndromes and tumors of the NC lineage (<xref ref-type="bibr" rid="c39">Medina-Cuadra and Monsoro-Burq, 2021</xref>). These neurocristopathies highlight the need to better understand the molecular basis of key processes in NC development, including EMT and collective migration.</p>
<p>HtrA1 belongs to a conserved family of serine proteases that are homologous to the heat shock-induced HtrA (<underline>H</underline>igh temperature <underline>r</underline>equirement <underline>A</underline>) peptidase from bacteria and primarily involved in protein quality control and degradation (<xref ref-type="bibr" rid="c75">Zurawa-Janicka et al., 2017</xref>). Vertebrate HtrA proteases, comprising the four members HtrA1-4, share a trypsin serine protease domain and a carboxy-terminal PDZ domain with their bacterial counterpart. The HtrA family is implicated in various pathological conditions including cancer, arthritis, neurodegenerative diseases, and pregnancy disorders. HtrA1 modulates the extracellular matrix and cell signaling as a secreted protein but was found to be active in the cytoplasm and nucleus, too (<xref ref-type="bibr" rid="c14">Clawson et al., 2008</xref>; <xref ref-type="bibr" rid="c12">Chien et al., 2009a</xref>,<xref ref-type="bibr" rid="c13">b</xref>; <xref ref-type="bibr" rid="c10">Campioni et al., 2010</xref>). The function of HtrA1 in cell migration has been studied <italic>in vitro</italic> to reveal mainly a negative role, although also a positive role has been reported (<xref ref-type="bibr" rid="c48">Pei et al., 2015</xref>). How HtrA1 activities are regulated is poorly understood, and the mechanism by which this protease affects cell migration <italic>in vivo</italic> remains elusive.</p>
<p>Members of the serpin superfamily contain a carboxyterminal reactive center loop that covalently binds to and inhibits target serine proteases inside and outside of cells (<xref ref-type="bibr" rid="c45">Olson and Gettins, 2011</xref>). Serpin peptidase inhibitor clade E member 2 (SerpinE2), also known as Protease Nexin-1 (PN1) or Glia-Derived Nexin (GDN) has important roles in the nervous, blood and reproductive systems (<xref ref-type="bibr" rid="c6">Arocas and Bouton, 2015</xref>; <xref ref-type="bibr" rid="c42">Monard, 2017</xref>). SerpinE2 also functions as a key factor in tumor dissemination, but the molecular mechanism by which this protease inhibitor governs cell migration and metastasis is largely unknown.</p>
<p>We previously showed that HtrA1 and SerpinE2 are transcriptionally induced by fibroblast growth factor (FGF) signals and act as feedback regulators of FGF/Erk signaling in germ layer and anteroposterior axis formation in the early <italic>Xenopus</italic> embryo (<xref ref-type="bibr" rid="c25">Hou et al., 2007</xref>; <xref ref-type="bibr" rid="c1">Acosta et al., 2015</xref>). HtrA1 activates Erk (extracellular signal-regulated kinase) and expression of the transcription factor Brachyury in the posterior mesoderm, whereas SerpinE2 suppresses Erk activation and <italic>Brachyury</italic> expression in the anterior ectoderm. The HtrA1 protease releases FGF ligands by triggering the cleavage of cell surface proteoglycans such as Syndecan-4 (Sdc4), thereby stimulating FGF/Erk signaling in mesoderm and trunk/tail formation (<xref ref-type="bibr" rid="c25">Hou et al., 2007</xref>). SerpinE2 binds to and inhibits HtrA1, thus restricting FGF/Erk signaling and allowing ectoderm and head formation to occur (<xref ref-type="bibr" rid="c1">Acosta et al., 2015</xref>). Since SerpinE2 and HtrA1 exhibit overlapping gene expression in the NC, we now asked whether these proteins might have a role in NC development.</p>
<p>Here, we introduce SerpinE2 as a key player in collective NC cell migration. We show that SerpinE2 promotes NC cell migration via inhibition of the extracellular serine protease HtrA1. SerpinE2 de-represses the HtrA1-mediated block of NC migration in mRNA-injected embryos, and the ability of this protease inhibitor to rescue cell migration depends on its extracellular location and intact reactive center loop. In epistatic experiments, Sdc4 mRNA can partly revert the NC migration defects that are induced by SerpinE2 knockdown or HtrA1 overexpression. We conclude that the SerpinE2/HtrA1/Sdc4 pathway regulates neural crest cell migration in the developing embryo.</p>
</sec>
<sec id="s2">
<title>Results</title>
<sec id="s2a">
<title><italic>SerpinE2</italic> and <italic>HtrA1</italic> are expressed in neural crest cells</title>
<p>The expression of <italic>SerpinE2</italic> and <italic>HtrA1</italic> in early <italic>Xenopus</italic> embryos was previously reported by us and others (<xref ref-type="bibr" rid="c49">Pera et al., 2005</xref>; <xref ref-type="bibr" rid="c46">Onuma et al., 2006</xref>; <xref ref-type="bibr" rid="c25">Hou et al., 2007</xref>; <xref ref-type="bibr" rid="c1">Acosta et al., 2015</xref>). To investigate whether these genes are expressed in the developing NC, we performed whole-mount <italic>in situ</italic> hybridization analysis of these genes side by side with the NC marker <italic>Twist</italic> (<xref rid="fig1" ref-type="fig">Figure 1</xref>). At neurula stage 17, <italic>Twist</italic> expression labelled pre-migratory NC cells in the deep layer of the ectoderm (<xref rid="fig1" ref-type="fig">Figure 1A,A’</xref>; <xref ref-type="bibr" rid="c24">Hopwood et al., 1989</xref>). <italic>SerpinE2</italic> transcripts were found in the deep layer of the neural plate and adjacent NC cells (<xref rid="fig1" ref-type="fig">Figure 1B-B’</xref>). <italic>HtrA1</italic> was transcribed in the superficial layer of the neural plate and in the NC (<xref rid="fig1" ref-type="fig">Figure 1C,C’</xref>). At stage 26, <italic>SerpinE2</italic> and <italic>HtrA1</italic> were co-expressed with <italic>Twist</italic> in ventrally migrating NC cells in the mandibular, hyoid, anterior branchial and posterior branchial streams (numbered as 1 to 4 in <xref rid="fig1" ref-type="fig">Figure 1D-F</xref>; see also Figure 1-figure supplement 1A-D). Importantly, <italic>SerpinE2</italic> transcripts accumulated at the ventral leading front, while <italic>HtrA1</italic> expression was abundant in more dorsal follower cells within the migrating NC cohorts (<xref rid="fig1" ref-type="fig">Figure 1D’-F’</xref>; see also Figure 1-figure supplement 1E-G). In addition, <italic>SerpinE2</italic> and <italic>HtrA1</italic> shared overlapping expression in the brain, eye vesicles and otic placodes (<xref rid="fig1" ref-type="fig">Figure 1E,F</xref>; see also Figure 1-figure supplement 1F,G). These results showed that <italic>SerpinE2</italic> and <italic>HtrA1</italic> are expressed in pre-migratory NC cells and adjacent tissues (<xref rid="fig1" ref-type="fig">Figure 1G</xref>), and that the SerpinE2 inhibitor transcripts prevails in the leading edge and the HtrA1 protease expression is predominant in the following migratory NC cells (<xref rid="fig1" ref-type="fig">Figure 1H</xref>).</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1.</label>
<caption><title>SerpinE2 and HtrA1 are expressed in the neural crest</title>
<p><italic>Xenopus</italic> embryos were analyzed by whole-mount <italic>in situ</italic> hybridization.</p>
<p><bold>(A-C)</bold> Anterior view of embryos at stage 17. The brackets point to pre-migratory NC cells on each side of the neural plate. The numbers label the <italic>Twist</italic>-expressing cranial NC segments: 1, mandibular; 2, hyoid; 3, anterior branchial; 4, posterior branchial. Arrowheads show <italic>SerpinE2</italic> and <italic>HtrA1</italic> transcripts in the trunk NC. The stippled lines indicate the level of sections in A’-C’. <bold>(A’-C’)</bold> Transversally hemisectioned embryos. <italic>SerpinE2</italic> and <italic>HtrA1</italic> signals appear in the NC (strippled circle lines). Note that <italic>SerpinE2</italic> is also expressed in the inner sensorial layer of the neural plate and underlying notochord, whereas <italic>HtrA1</italic> expression is more abundant in the outer ependymal layer of the neural plate.</p>
<p><bold>(D-F)</bold> Lateral view of embryos at stage 26. <italic>SerpinE2</italic> and <italic>HtrA1</italic> are expressed in <italic>Twist</italic><sup>+</sup> NC cell streams (1-4). Transcripts of both genes can also be seen in the brain, eye and otic placode.</p>
<p><bold>(D’-F’)</bold> Magnification of embryos. Arrowheads demarcate <italic>SerpinE2</italic> transcripts near the front (E’) and <italic>HtrA1</italic> transcripts at the rear end (F’) of the migrating NC cell collectives in the anterior branchial arch (3) and posterior branchial arch (4).</p>
<p><bold>(G, H)</bold> Summary of gene expression domains. At stage 17, <italic>SerpinE2</italic> is transcribed in ventral and <italic>HtrA1</italic> in dorsal cells of the pre-migratory NC (G). At stage 26, <italic>SerpinE2</italic> is expressed in leader cells and <italic>HtrA1</italic> in follower cells of migrating NC streams (H).</p>
<p>ey, eye; hb, hindbrain; NC, neural crest; np, neural plate; nt, notochord; ot, otic placode. Scale bar, 0.5 mm.</p></caption>
<graphic xlink:href="556243v2_fig1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2b">
<title>SerpinE2 knockdown reproduces the phenotype of neural crest extirpation in <italic>Xenopus</italic> embryos</title>
<p>Classical extirpation experiments carried out in the urodele <italic>Amblystoma</italic> demonstrated that the cranial NC is important for the formation of the head tissue (<xref ref-type="bibr" rid="c62">Stone, 1922</xref>,<xref ref-type="bibr" rid="c63">1926</xref>) and the trunk NC for dorsal fin and melanocyte development (Du Shane, 1936). We reproduced these findings in the <italic>Xenopus</italic> embryo and showed that bilateral removal of the neural folds (anlagen of the NC) in the cranial and anterior trunk region at mid-neurula stage (stage 17) resulted in larvae displaying a reduced head size, missing dorsal fin (open arrowheads) and reduced melanocyte pigmentation (arrow) (<xref rid="fig2" ref-type="fig">Figure 2A-C</xref>).</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2.</label>
<caption><title>Knockdown of SerpinE2 mimics the phenotype of neural excision and inhibits migration of neural crest cells</title>
<p><bold>(A)</bold> Scheme of extirpation. Dorsal view of <italic>Xenopus</italic> embryo at stage 17, from which NC tissue was removed on both sides.</p>
<p><bold>(B,C)</bold> Tadpole embryo at stage 40 following NC excision (B) and sibling control (C). Note the small head, absence of dorsal fin tissue (open arrowheads) and the reduced number of melanocytes (arrow) resulting from NC extirpation in A.</p>
<p><bold>(D)</bold> Unaffected tadpole after microinjection with control-MO into all animal blastomeres at the 8-cell stage. Highlighted are the pigmented melanocytes (arrow) and the intact dorsal fin (filled arrowheads).</p>
<p><bold>(E)</bold> <italic>SerpinE2</italic>-MO causes a reduction of head tissue, dorsal fin structures (open arrowheads) and melanocytes (arrow).</p>
<p><bold>(F)</bold> Co-injection of <italic>SerpinE2</italic>-MO and 2 ng non-targeted <italic>Flag-SerpinE2</italic> mRNA restores a normal phenotype.</p>
<p><bold>(G)</bold> Scheme for microinjections in K-W. MOs and mRNAs were injected together with 100 pg <italic>nlacZ</italic> mRNA as lineage tracer (red nuclei) into one dorsal animal blastomere of embryos at the 8-cell stage. The injected side is marked with a star.</p>
<p><bold>(H-Q)</bold> Anterior view of neurula embryos. Neither control-MO nor <italic>SerpinE2</italic>-MO affect <italic>Twist</italic> and <italic>Sox9</italic> expression in NC cells in the head and trunk (arrows) at stage 18 (H-K). <italic>SerpinE2</italic>-MO inhibits the EMT of <italic>Foxd3</italic><sup>+</sup> and <italic>Snail2</italic><sup>+</sup> NC cells (open arrowheads) at stage 20, whereas the control-MO and <italic>SerpinE2</italic>-5MM-MO have no effect (filled arrowheads) (L-Q).</p>
<p><bold>(R-T)</bold> Lateral view of stage 26 embryos. A single injection of control-MO does not affect the migration of <italic>Snail1</italic><sup>+</sup> NC cells (filled arrowhead). <italic>SerpinE2</italic>-MO leads to a migration defect on the injected side (open arrowhead). 333 pg <italic>Flag-SerpinE2</italic> mRNA rescues NC migration in the <italic>SerpinE2</italic>-morphant embryo.</p>
<p>br, branchial crest segment; ey, eye primordium; hy, hyoid crest segment; ma, mandibular crest segment; MO, morpholino oligonucleotide; NC, neural crest; ot, otic vesicle. Doses of injected MOs per embryo were 40 ng (D-I) and 10 ng (H-T). Indicated phenotypes were shown in B, 10/11; D, 89/90; E, 64/83; F, 122/132; H, 29/29; I, 24/26; J, 7/7; K, 10/11; L, 9/9; M, 7/7; N, 7/9; O, 7/8; P, 8/9; Q, 9/11; R, 10/10; S, 13/15; T, 9/9. Scale bar, 0.5 mm.</p></caption>
<graphic xlink:href="556243v2_fig2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>The expression pattern prompted us to investigate the function of SerpinE2 in NC development. <italic>Xenopus laevis</italic> is allotetraploid (<xref ref-type="bibr" rid="c59">Session et al., 2016</xref>) and contains two <italic>SerpinE2</italic> genes, namely <italic>SerpinE2.L</italic> (<italic>PN1.a</italic>) and <italic>SerpinE2.S</italic> (<italic>PN1.b</italic>), which encode two proteins that share 96% amino acid identity. A combination of two antisense morpholino oligonucleotides (MOs) that target the translation initiation site of <italic>SerpinE2.L</italic> and one MO directed against <italic>SerpinE2.S</italic> (collectively termed <italic>SerpinE2</italic>-MO) efficiently blocks SerpinE2 protein biosynthesis in <italic>Xenopus</italic> embryos (<xref ref-type="bibr" rid="c1">Acosta et al., 2015</xref>). We previously noted reduction of head structures in tadpoles upon microinjection of <italic>SerpinE2</italic>-MO into the animal pole blastomeres at the 8-cell stage. A closer analysis now revealed that these <italic>SerpinE2</italic>-morphant embryos also exhibited a loss of dorsal fin structures (open arrowheads) and a decreased number of melanocytes (arrow) at stage 40 (<xref rid="fig2" ref-type="fig">Figure 2E</xref>). These phenotypes were specific, since a standard control-MO had no phenotypic effect (<xref rid="fig2" ref-type="fig">Figure 2D</xref>), and co-injection of <italic>SerpinE2</italic>-MO together with a <italic>Flag-SerpinE2</italic> mRNA that is not targeted by the MO, rescued normal development (<xref rid="fig2" ref-type="fig">Figure 2F</xref>). The striking similarity of the phenotype obtained after knockdown of SerpinE2 with that of NC extirpation (<xref rid="fig2" ref-type="fig">Figure 2A-C</xref>) and supporting evidence from fate mapping studies that NC cells contribute to head mesenchyme, dorsal fin structures, and melanocytes (<xref ref-type="bibr" rid="c67">Tucker, 1986</xref>; <xref ref-type="bibr" rid="c54">Sadaghiani and Thiébaud, 1987</xref>; <xref ref-type="bibr" rid="c68">Tucker and Slack, 2004</xref>) suggest that SerpinE2 might be important for NC development.</p>
</sec>
<sec id="s2c">
<title>SerpinE2 is dispensable for the specification but essential for the migration of neural crest cells</title>
<p>We used single injections into the animal pole at 8-cell stage embryos of MOs together with <italic>nlacZ</italic> mRNA as lineage tracer (red nuclei) to identify the injected side and ensure that the MO is properly targeted (<xref rid="fig2" ref-type="fig">Figure 2G</xref>). <italic>SerpinE2</italic>-MO does not appear to affect NC specification in the head and trunk, as the expression of <italic>Twist</italic>, <italic>Sox9</italic>, <italic>cMyc</italic>, <italic>Foxd3</italic>, <italic>Snail1</italic> and <italic>Snail2</italic> in pre-migratory NC cells remained unchanged in mid-neurula embryos at stage 18 (<xref rid="fig2" ref-type="fig">Figure 2H-K</xref>; see also Figure 2-figure supplement 1).</p>
<p>Since migration of the NC is initiated progressively from anterior to posterior in the neural folds of the closing neural tube (<xref ref-type="bibr" rid="c54">Sadaghiani and Thiébaud, 1987</xref>), we chose two distinct stages to monitor the EMT and migration of this cell population. At stage 20, NC cells of the mandibular crest segment are migrating from the mesencephalon around the eye primordium, while cells of the hyoid and branchial crest segments are undergoing EMT in the rhombencephalon (<xref rid="fig2" ref-type="fig">Figure 2L,O</xref>). At stage 26, NC cell migration occurs in the hyoid segment anterior to the otic vesicle, and in two split branchial segments posterior to the ear primordium (<xref rid="fig2" ref-type="fig">Figure 2R</xref>). A single dorsal injection of <italic>SerpinE2</italic>-MO caused a delay or failure of these NC cells to undergo EMT and migration (open arrowheads) in advanced neurula (<xref rid="fig2" ref-type="fig">Figure 2M,P</xref>) and tailbud embryos (<xref rid="fig2" ref-type="fig">Figure 2S</xref>). These knockdown effects were specific, because a <italic>SerpinE2</italic>-5MM-MO, which contains five mismatches with the <italic>SerpinE2.L</italic> and <italic>SerpinE2.S</italic> target mRNA sequences, as well as a combination of <italic>SerpinE2</italic>-MO and non-targeted <italic>Flag-SerpinE2</italic> mRNA failed to disrupt NC migration (<xref rid="fig2" ref-type="fig">Figure 2N,Q,T</xref>; see also <xref rid="fig8" ref-type="fig">Figure 8B-E’</xref> and Figure 8-figure supplement 1A,B below). Ventrally injected <italic>SerpinE2</italic>-MO was less efficient in reducing NC migration (Figure 8-figure supplement 1C,D), because expression of the <italic>SerpinE2</italic> is highest in dorsal regions of post-gastrula embryos (<xref rid="fig1" ref-type="fig">Figure 1B</xref>). We conclude that SerpinE2 is dispensable for the initial specification but necessary for the migration of NC cells in <italic>Xenopus</italic> embryos.</p>
</sec>
<sec id="s2d">
<title>HtrA1 inhibits the development and migration of neural crest cells</title>
<p>Next, we investigated whether HtrA1 affects NC development (<xref rid="fig3" ref-type="fig">Figure 3</xref>). Injection of <italic>HtrA1</italic> mRNA into the animal pole blastomeres led to a decrease of head and eye structures in early tadpole embryos (<xref rid="fig3" ref-type="fig">Figure 3A,B</xref>) in accordance with the previously reported axis posteriorizing activity of this protease (<xref ref-type="bibr" rid="c25">Hou et al., 2007</xref>). <italic>HtrA1</italic> overexpression also caused a reduction of dorsal fin tissue (open arrowheads) and fewer melanocytes (arrow), suggesting that HtrA1 inhibits the formation of NC-derived structures.</p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3.</label>
<caption><title>HtrA1 protease inhibits the formation of neural crest-derived structures and reduces neural crest migration</title>
<p>Embryos were injected into all animal blastomeres (A-H) or a single dorsal animal blastomere (I-P) at the 8-cell stage.</p>
<p><bold>(A-D)</bold> Tadpoles at stage 40. <italic>HtrA1</italic> mRNA causes reduction of head tissue, dorsal fin structures (arrowheads) and melanocytes (arrow), whereas <italic>HtrA1(S307A)</italic> and <italic>Flag-HtrA1ΔSP</italic> mRNA have no effect.</p>
<p><bold>(E-G)</bold> Anterior view of embryos at stage 18. Stars demarcate the injected sides. Neither 65 pg <italic>HtrA1</italic> mRNA nor 10 ng <italic>HtrA1</italic>-MO do affect the specification of <italic>Twist</italic><sup>+</sup> cranial NC cells. <bold>(H,I)</bold> Anterior view of embryos at stage 20. 65 pg <italic>HtrA1</italic> mRNA reduces the EMT of <italic>Foxd3</italic><sup>+</sup> cranial NC cells (arrowheads) but does not affect the specification of trunk NC cells (arrows).</p>
<p><bold>(J-L)</bold> Lateral view of embryos at stage 26. The migration of NC cells (arrowheads) is reduced by 65 pg <italic>HtrA1</italic> mRNA but not affected by 10 ng <italic>HtrA1</italic>-MO.</p>
<p>br, branchial crest segment; hy, hyoid crest segment; ma, mandibular crest segment. Unless otherwise noted, the mRNA doses of <italic>HtrA1</italic> and derived constructs per embryo were 100 pg. Indicated phenotypes were shown in B, 98/100; C, 74/83; D, 84/87; E, 31/31; F, 51/53; G, 59/60; H, 28/31; I, 23/26; J, 9/10; K, 21/21; L, 58/79 embryos; at least two independent experiments.</p>
<p>Scale bar, 0.5 mm.</p></caption>
<graphic xlink:href="556243v2_fig3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>A single dorsal injection of <italic>HtrA1</italic> mRNA did not affect the expression of cranial and trunk NC markers (<xref rid="fig3" ref-type="fig">Figure 3E,F</xref>) but blocked EMT and migration of NC cells (<xref rid="fig3" ref-type="fig">Figure 3H-K</xref> and <xref rid="fig6" ref-type="fig">Figure 6B-C’</xref> below). Quantitative analysis showed that HtrA1 overexpression caused migratory defects at stages 20 and 26 in a concentration-dependent manner (Figure 6-figure supplement 1A,B). Ventral mRNA injection of <italic>HtrA1</italic>-derived constructs does not properly target the NC and therefore was less effective in inhibiting the migration of this cell population (Figure 6-figure supplement 1C,D).</p>
<p>Using Western blot analysis with a polyclonal anti-HtrA1 antibody, we previously showed that a morpholino oligonucleotide directed against <italic>HtrA1.L</italic> and <italic>HtrA1.S</italic>, designated <italic>HtrA1</italic>-MO, efficiently blocks endogenous HtrA1 protein expression in <italic>Xenopus</italic> embryos (<xref ref-type="bibr" rid="c25">Hou et al., 2007</xref>). Dorsal injection of <italic>HtrA1</italic>-MO failed both to affect the induction of the NC marker <italic>Twist</italic> (<xref rid="fig3" ref-type="fig">Figure 3G</xref>) and to alter the migration of <italic>Twist<sup>+</sup></italic> NC cells (<xref rid="fig3" ref-type="fig">Figure 3L</xref>), suggesting that knockdown of HtrA1 appears not to affect NC development. We conclude that upregulation of HtrA1 protease activity inhibits the migration but not the specification of NC cells.</p>
</sec>
<sec id="s2e">
<title>HtrA1 and SerpinE2 control the development of the head cartilage skeleton</title>
<p>Cranial neural crest cells contribute to the craniofacial skeleton (<xref ref-type="bibr" rid="c54">Sadaghiani and Thiébaud, 1987</xref>). The mandibular crest stream gives rise to the ethmoid-traberculum (upper jaw), palatoquadrate and Meckel’s cartilage (lower jaw); the hyoid crest stream supplies the ceratohyal cartilage; and the branchial crest streams forms the paired ceratobranchial cartilages (gills) (<xref rid="fig4" ref-type="fig">Figure 4L</xref>). The transcription factor Sox9 is a master regulator of chondrogenesis that mediates the condensation of chondrogenic mesenchyme and chondrocyte differentiation (<xref ref-type="bibr" rid="c64">Suzuki et al., 2012</xref>). In early tadpoles at stages 40/41, <italic>Sox9</italic> expression demarcates chondrogenic precursors in the head mesenchyme (<xref rid="fig4" ref-type="fig">Figure 4A,A’</xref>). Upon microinjection of <italic>HtrA1</italic> mRNA into the animal pole of all blastomeres at the 4-cell stage, <italic>Sox9</italic> expression was reduced in developing cartilage structures (<xref rid="fig4" ref-type="fig">Figure 4B,B’</xref>). A similar reduction of <italic>Sox9</italic><sup>+</sup> cartilaginous elements was induced by <italic>SerpinE2</italic>-MO, whereas the control-MO had no effect (<xref rid="fig4" ref-type="fig">Figure 4C-D’</xref>). The results suggest that HtrA1 overexpression and SerpinE2 knockdown impair with craniofacial cartilage formation.</p>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4.</label>
<caption><title>HtrA1 overexpression and SerpinE2 knockdown decrease cartilaginous elements and craniofacial structures</title>
<p><italic>Xenopus</italic> embryos were injected into four animal blastomeres at the 8-cell stage with a total of 100 pg mRNA and 40 ng morpholino oligonucleotides (MOs).</p>
<p><bold>(A-D’)</bold> Tadpoles at stages 40/41 after whole-mount <italic>in situ</italic> hybridization in lateral (A-D) and ventral view (A’-D’). Note that <italic>HtrA1</italic> mRNA and <italic>SerpinE2</italic>-MO reduce <italic>Sox9</italic> expression, whereas control-MO has no effect on the labelled cartilaginous elements.</p>
<p><bold>(E-K)</bold> Ventral view of cartilaginous skeleton extracted from embryos at stage 46 after Alcian Blue staining. The dorsal ethmoid-trabecular cartilage was removed for better visibility. Note that <italic>HtrA1</italic> mRNA, but not <italic>HtrA1(S307A)</italic> and <italic>Flag-HtrA1ΔSP</italic> mRNAs, diminishes craniofacial structures (E-H). <italic>SerpinE2</italic>-MO, but not control-MO nor a combination of <italic>SerpinE2</italic>-MO and <italic>Flag-SerpinE2</italic> mRNA, reduce head skeleton structures (I-K).</p>
<p><bold>(L)</bold> Scheme of the cartilaginous skeleton at stage 46 in ventral view. Indicated is the contribution of neural crest streams to the craniofacial skeleton elements. cb, ceratobranchial; ch, ceratohyal; et, ethmoid-trabecular; mc, Meckel’s cartilage; pq, palatoquadrate.</p>
<p>Indicated phenotypes were shown in A, 11/11; B, 17/19; C, 12/13; D, 15/17; E, 57/58; F, 17/21; G, 72/77; H, 67/78; I, 83/88; J, 73/77; K, 77/87 embryos; at least two independent experiments. Scale bar, 0.5 mm.</p></caption>
<graphic xlink:href="556243v2_fig4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Alcian Blue staining was used to visualize the cartilaginous skeleton in <italic>Xenopus</italic> tadpoles at stages 46 (<xref rid="fig4" ref-type="fig">Figure 4E</xref>). For quantification of the skeleton size, we measured the width at the level of the anterior ceratobranchial cartilages (Figure 4-figure supplement 1A). <italic>HtrA1</italic> mRNA injection reduced all cartilage structures and lowered the size of the head skeleton by 21% (<xref rid="fig4" ref-type="fig">Figure 4F</xref>, Figure 4-figure supplement 1B,E). Similarly, <italic>SerpinE2</italic>-MO decreased the skeleton size by 22% compared to control-morphant siblings (<xref rid="fig4" ref-type="fig">Figure 4I,J</xref>, Figure 4-figure supplement 2A,B,D). The coiling pattern of the gut was not affected in <italic>SerpinE2</italic>-morphant tadpoles (Figure 4-figure supplement 2B, arrowhead), ruling out an overall delay of embryonic development. Co-injection of <italic>SerpinE2</italic>-MO together with non-targeted <italic>Flag-SerpinE2</italic> mRNA rescued craniofacial skeleton development (<xref rid="fig4" ref-type="fig">Figure 4K</xref>, Figure 4-figure supplement 2C,D). We conclude that HtrA1 and SerpinE2 regulate the formation of NC-derived cartilage structures.</p>
</sec>
<sec id="s2f">
<title>HtrA1 and SerpinE2 act in the neural crest to regulate cell adhesion on fibronectin</title>
<p>Since HtrA1 and SerpinE2 are expressed in both NC cells and surrounding tissue, we asked whether the proteins affect cell migration in a NC-autonomous or non-autonomous manner. The cranial NC can be dissected from <italic>Xenopus</italic> embryos at stage 17 and cultured on fibronectin <italic>in vitro</italic> to investigate collective cell migration in relative isolation, allowing for the identification of extrinsic versus intrinsic mechanisms (<xref rid="fig5" ref-type="fig">Figure 5A</xref>; <xref ref-type="bibr" rid="c4">Alfandari et al., 2003</xref>). After 4 hours, cells from uninjected explants spread as a coherent sheet towards one side and thereby doubled the surface area compared to the time of plating (<xref rid="fig5" ref-type="fig">Figure 5B-B’’,F</xref>, filled arrowhead). In contrast, little cell migration was observed in explants upon injection with <italic>HtrA1</italic> mRNA, contributing to only a 20% increase in surface area within this time frame (<xref rid="fig5" ref-type="fig">Figure 5C-C’’,F</xref>, open arrowhead). Similarly, <italic>SerpinE2</italic>-MO inhibited cell migration, leading to only one tenth of the increase in total surface area that was observed in control-morphant explants (<xref rid="fig5" ref-type="fig">Figure 5D-E’’,F</xref>). At 7 hours after plating, distinct segments were seen in uninjected and control-MO-injected explants (<xref rid="fig5" ref-type="fig">Figure 5B’’’,D’’’</xref>), resembling the mandibular, hyoid, and branchial streams seen in sibling control embryos at the tailbud stage (<xref rid="fig1" ref-type="fig">Figure 1D</xref>). In contrast, explants injected with either <italic>HtrA1</italic> mRNA or <italic>SerpinE2</italic>-MO failed to display segmentation into distinct streams (<xref rid="fig5" ref-type="fig">Figure 5C’’’,E’’’</xref>). In time-lapse video microscopy, control-MO-injected explants exhibited lamellipodia and filopodia at the leading front of the migratory NC cell clusters (<xref rid="fig5" ref-type="fig">Figure 5</xref>-video 1). <italic>SerpinE2</italic>-morphant NC cells lost polarity and took on a spherical appearance (<xref rid="fig5" ref-type="fig">Figure 5</xref>-video 2). These results show that both HtrA1 overexpression and SerpinE2 knockdown inhibit collective cell migration <italic>in vitro</italic>, providing evidence that HtrA1 and SerpinE2 regulate cell migration in the isolated NC.</p>
<fig id="fig5" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5.</label>
<caption><title>HtrA1 overexpression of and SerpinE2 knockdown inhibit cranial neural crest cell migration and adhesion to fibronectin <italic>in vitro</italic></title>
<p><bold>(A)</bold> Scheme of migration experiment. The cranial neural crest was explanted from uninjected or injected embryos at stage 17 and cultured on a fibronectin-covered plastic plate.</p>
<p><bold>(B-E’’’)</bold> Time lapse of cell migration in CNC explants after culturing for 0, 4 or 7 hours. Note collective cell migration (filled arrowheads) in uninjected controls and explants injected with control-MO, whereas <italic>HtrA1</italic> mRNA and <italic>SerpinE2</italic>-MO block migration (open arrowheads). In B’’-E’’, the surface areas of explants at 0 hours (blue) and 4 hours (red) were determined by ImageJ and superimposed. Scale bar, 0.2 mm</p>
<p><bold>(F)</bold> Quantification of initial CNC migration. Indicated is the surface ratio of explants 4 hours versus 0 hours after plating. 12 explants were analyzed per sample; two independent experiments.</p>
<p><bold>(G)</bold> Scheme of adhesion experiment. Upon injection of <italic>eGFP</italic> mRNA, CNC eplants were dissociated in Ca<sup>2+</sup>- and Mg<sup>2+</sup>-free medium, and single cells were cultured on a fibronectin plate. <bold>(H-K)</bold> Single eGFP-labelled CNC cells after 1 hour culture. Note adhering cells with extended cytoplasmic processes (filled arrowheads) in control sample and after co-injection with control-MO, whereas <italic>HtrA1</italic> mRNA and <italic>SerpinE2</italic>-MO prevent adhesion causing injected cells to acquire a round phenotype (open arrowheads). Scale bar, 0.02 mm.</p>
<p><bold>(L)</bold> Quantification of CNC adhesion. Indicated is the ratio of adherent cells relative to the control. Analysis of n&gt;1600 cells from at least 6 explants per sample; two independent experiments. CNC, cranial neural crest; GFP, green fluorescent protein. Embryos were injected with 100 pg mRNAs and 40 ng MOs.</p></caption>
<graphic xlink:href="556243v2_fig5.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>To examine cell-matrix adhesion, we dissociated cranial NC explants in Ca<sup>2+</sup>/Mg<sup>2+</sup>-free medium and cultured them as single cells on fibronectin (<xref rid="fig5" ref-type="fig">Figure 5G</xref>). For better visibility of the NC cells, the donor embryos were injected with mRNA for enhanced green-fluorescent protein (eGFP). At 1 hour after plating, eGFP<sup>+</sup> cells adhered to fibronectin and extended cytoplasmic processes to this extracellular matrix protein (<xref rid="fig5" ref-type="fig">Figure 5H</xref>, filled arrowhead). Upon injection of <italic>HtrA1</italic> mRNA, nearly 80% of cells failed to attach and acquired a round morphology (<xref rid="fig5" ref-type="fig">Figure 5I</xref> and <xref rid="fig5" ref-type="fig">Figure 5L</xref>, open arrowhead). Similarly, <italic>SerpinE2</italic>-MO-injected cells lost adherence and cytoplasmic extensions, whereas the control-MO had no significant effect (<xref rid="fig5" ref-type="fig">Figure 5J-L</xref>). We conclude from these <italic>in vitro</italic> explant and single cell data that HtrA1 and SerpinE2 regulate NC cell adhesion and migration on fibronectin.</p>
</sec>
<sec id="s2g">
<title>HtrA1 controls neural crest migration as a secreted protease</title>
<p>HtrA1 contains a cleavable N-terminal signal peptide (SP), a trypsin-like serine protease domain and a carboxyterminal PDZ (<underline>P</underline>ost-synaptic density of 95kD, <underline>D</underline>iscs large, <underline>Z</underline>ona occludens-1) protein-protein interaction domain (<xref rid="fig6" ref-type="fig">Figure 6A</xref>, top left; <xref ref-type="bibr" rid="c75">Zurawa-Janicka et al., 2017</xref>). The SP is a short hydrophobic peptide sequence that destines proteins normally to the secretory pathway (<xref ref-type="bibr" rid="c47">Owji et al., 2018</xref>). We previously identified <italic>Xenopus</italic> HtrA1 as a protein in the supernatant of cDNA-transfected and metabolically labelled HEK 293T cells (<xref ref-type="bibr" rid="c25">Hou et al., 2007</xref>), suggesting that the protease might act in the extracellular space. On the other hand, human HtrA1 has been shown to associate with and stabilize microtubules in a PDZ domain-dependent manner (<xref ref-type="bibr" rid="c13">Chien et al., 2009b</xref>), raising the possibility for a non-proteolytic function of cytosolic HtrA1 in the regulation of cell motility. In a structure-function analysis, we investigated (1) whether HtrA1 acts as a protease in NC development, (2) whether HtrA1 operates in the extracellular space or inside the cell, and (3) whether its PDZ domain is involved in regulating NC migration. To this end, we compared with their cognate wild type HtrA1 constructs three mutant derivatives, including HtrA1(S307A), in which the catalytic serine residue in amino acid position 307 is replaced by alanine (<xref ref-type="bibr" rid="c25">Hou et al., 2007</xref>), a newly generated Flag-tagged construct that lacks the secretory signal peptide (Flag-HtrA1ΔSP), and a myc-tagged construct that is devoid of the PDZ domain (HtrA1ΔPDZ-myc; <xref ref-type="bibr" rid="c1">Acosta et al., 2015</xref>) (<xref rid="fig6" ref-type="fig">Figure 6A</xref>).</p>
<fig id="fig6" position="float" orientation="portrait" fig-type="figure">
<label>Figure 6.</label>
<caption><title>HtrA1 inhibits neural crest migration as an extracellular protease</title>
<p>Embryos were injected into a single dorsal animal blastomere at the 8-cell stage. A star labels the injected side. <italic>Twist</italic> expression demarcates the NC in embryos at stage 20 (B-G; anterior view) and stage 26 (B’-G’; lateral view).</p>
<p><bold>(A)</bold> Overview of wild type (top) and mutant (bottom) HtrA1 protein constructs.</p>
<p><bold>(B-E’)</bold> <italic>HtrA1</italic> mRNA, but neither <italic>Flag-HtrA1ΔSP</italic> nor <italic>HtrA1(S307A)</italic> mRNAs, reduces EMT and migration of NC cells on the injected side (arrowheads). Note that the diffusible HtrA1 protein reduces NC cell migration to a lower extent also on the non-injected side.</p>
<p><bold>(F-G’)</bold> Both <italic>HtrA1-myc</italic> and <italic>HtrA111PDC-myc</italic> mRNAs reduce NC EMT and migration.</p>
<p>br, branchial segment; hy, hyoid segment; ma, mandibular segment. Injected mRNA doses per embryos are 65 pg. For quantification of NC migration defects, see Figure 6-figure supplement 1A,B.</p></caption>
<graphic xlink:href="556243v2_fig6.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Using Western blot analysis, we previously reported that HtrA1(S307A) (<xref ref-type="bibr" rid="c25">Hou et al., 2007</xref>) and HtrA1ΔPDZ-myc (<xref ref-type="bibr" rid="c1">Acosta et al., 2015</xref>) generate proteins of the expected size in mRNA-injected <italic>Xenopus</italic> embryos. These mutant HtrA1 constructs co-immunoprecipitate with Flag-SerpinE2 at protein levels similar to their corresponding wild type HtrA1 and HtrA1-myc constructs (<xref ref-type="bibr" rid="c1">Acosta et al., 2015</xref>). Here we used Western blot analysis of lysates to show that the Flag-HtrA1 and Flag-HtrA1ΔSP protein constructs were expressed with the expected molecular weights in both cDNA-transfected HEK293T cells and mRNA-injected <italic>Xenopus</italic> embryos (Figure 6-figure supplement 2A,B,D). However, while the Flag-HtrA1 protein accumulated at high levels in the supernatant of transfected cells, the Flag-HtrA1ΔSP protein failed to be efficiently secreted into the culture medium (Figure 6-figure supplement 2C). We also showed that wild type Flag-HtrA1 and cytosolic Flag-HtrA1ΔSP degraded αTubulin, but not βActin, which validates the proteolytic activity and target specificity of these constructs (Figure 6-figure supplement 2B,E-G).</p>
<p>Neither <italic>HtrA1(S307A)</italic> nor <italic>Flag</italic>-<italic>HtrA1ΔSP</italic> affected NC migration in mRNA-injected embryos (<xref rid="fig6" ref-type="fig">Figure 6D-E’</xref>; see also Figure 6-figure supplement 1A,B). These two mutant constructs also failed to induce any defects in dorsal fin, melanocyte (<xref rid="fig3" ref-type="fig">Figure 3C,D</xref>) and craniofacial skeleton structures (<xref rid="fig4" ref-type="fig">Figure 4G,H</xref>; Figure 4-figure supplement 1C-E), suggesting that HtrA1 relies on an intact protease domain and a transport to the secretory pathway to regulate the development of these NC derivatives. <italic>HtrA1ΔPDZ-myc</italic> efficiently inhibited EMT and NC migration to a degree comparable to that induced by <italic>HtrA1-myc</italic> control mRNA (<xref rid="fig6" ref-type="fig">Figure 6F-G</xref>’; Figure 6-figure supplement 1A,B). These results support the conclusions that HtrA1 acts as an extracellular protease and that an association of HtrA1 via its PDZ domain to microtubuli appears not to regulate the migratory behavior of NC cells in the <italic>Xenopus</italic> embryo.</p>
</sec>
<sec id="s2h">
<title>SerpinE2 interacts with HtrA1 in neural crest cell migration</title>
<p>The serpin superfamily comprises extracellular and intracellular members with an exposed reactive center loop (RCL) that is cleaved by a target protease and irreversibly inhibits the attacking enzyme by forming a covalent serpin-protease complex (<xref ref-type="bibr" rid="c45">Olson and Gettins, 2011</xref>). SerpinE2 contains an N-terminal signal peptide and a C-terminal RCL (<xref rid="fig7" ref-type="fig">Figure 7A</xref>). We previously showed that SerpinE2 via its RCL binds to the trypsin domain of HtrA1 (<xref ref-type="bibr" rid="c1">Acosta et al., 2015</xref>). Do SerpinE2 and HtrA1 interact in NC cell migration? To this end, we used Flag-tagged SerpinE2 (Flag-SerpinE2), a point mutant Flag-SerpinE2pm derivative, in which two proline residues replace the critical arginine and serine residues (R362P and S363P) at the process site of the RCL, and a newly generated truncated construct that lacks the N-terminal signal peptide (Flag-SerpinE2ΔSP) (<xref rid="fig7" ref-type="fig">Figure 7A</xref>). In previous Western blot studies, we showed that Flag-SerpinE2 and Flag-SerpinE2pm are synthesized in similar protein amounts and at the expected sizes, but that overexpressed HtrA1 immunopreciptates Flag-SerpinE2pm less efficiently than Flag-SerpinE2 (<xref ref-type="bibr" rid="c1">Acosta et al., 2015</xref>). Here we use Western blotting to validate that Flag-SerpinE2ΔSP protein is generated in expected amount and size upon mRNA injection in <italic>Xenopus</italic> embryos (Figure 6-figure supplement 2A,D,E). However, unlike wild type Flag-SerpinE2, the signal peptide-deficient Flag-SerpinE2ΔSP construct is not efficiently secreted in cDNA-transfected HEK293 cells (Figure 6-figure supplement 2B,C).</p>
<fig id="fig7" position="float" orientation="portrait" fig-type="figure">
<label>Figure 7.</label>
<caption><title>SerpinE2 and HtrA1 interact with Sdc4 in neural crest cell migration</title>
<p>mRNAs were injected into one dorsal animal blastomere at the 8-cell stage. Embryos are shown in anterior view (stage 20, injected side labelled with a star, B-G) and lateral view (stage 26, B’-G’).</p>
<p><bold>(A)</bold> Overview of wild type (left) and mutant (right) SerpinE2 protein constructs.</p>
<p><bold>(B,B’)</bold> 4 ng <italic>Flag</italic>-<italic>SerpinE2</italic> mRNA has no effect on the migration of <italic>Twist</italic><sup>+</sup> NC cells (filled arrowheads).</p>
<p><bold>(C,C)</bold> Flag-HtrA1 inhibits NC cell migration robustly on the injected sides (open arrowheads).</p>
<p><bold>(D-F’)</bold> <italic>SerpinE2</italic> mRNA, but neither <italic>Flag-SerpinE2ΔSP</italic> nor <italic>SerpinE2pm</italic> mRNA, rescues normal EMT and migration of NC cells upon co-injection with <italic>Flag-HtrA1</italic>.</p>
<p><bold>(G,G’)</bold> <italic>Sdc4</italic> mRNA restores normal NC migration in <italic>Flag-HtrA1</italic>-injected embryos.</p>
<p>If not otherwise indicated, injected mRNA doses per embryos are 65 pg (<italic>Flag-HtrA1</italic>), 333 pg (<italic>Flag-SerpinE2</italic> derived constructs) and 450 pg (<italic>Sdc4</italic>). For quantification of NC migration defects, see Figure 7-figure supplement 1A,B.</p></caption>
<graphic xlink:href="556243v2_fig7.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Microinjection of <italic>Flag-SerpinE2</italic> mRNA at doses of up to 4 ng did not affect the migration of <italic>Twist</italic><sup>+</sup> NC cells (marked with nuclear lacZ lineage tracer) at stages 20 and 26 (<xref rid="fig7" ref-type="fig">Figure 7B,B’</xref>; see also Figure 7-figure supplement 1). However, co-injection of <italic>Flag-HtrA1</italic> and <italic>Flag-SerpinE2</italic> mRNAs reverted the EMT and NC migration defects that were induced by <italic>Flag-HtrA1</italic> mRNA alone (<xref rid="fig7" ref-type="fig">Figure 7C-D’</xref>; Figure 7-figure supplement 1), suggesting that SerpinE2 can relieve HtrA1-mediated suppression of NC migration. <italic>Flag-SerpinE2ΔSP</italic> failed to rescue the <italic>Flag-HtrA1</italic>-induced NC migration defects (<xref rid="fig7" ref-type="fig">Figure 7E,E’</xref>; Figure 7-figure supplement 1), underscoring that entry into the secretory pathway is important for the function of SerpinE2. Moreover, <italic>Flag-SerpinE2pm</italic> did not inhibit <italic>Flag-HtrA1</italic> mRNA from blocking NC migration (<xref rid="fig7" ref-type="fig">Figure 7F,F’</xref>; Figure 7-figure supplement 1). We conclude that SerpinE2 functions in the extracellular space and requires an intact RCL for efficient interaction with HtrA1 to modulate NC cell migration.</p>
</sec>
<sec id="s2i">
<title>Double knockdown of SerpinE2 and HtrA1 rescues neural crest migration</title>
<p>We next asked whether the NC migration defects induced by SerpinE2 depletion are dependent on endogenous HtrA1 protein. In loss-of-function experiments, we co-injected <italic>SerpinE2</italic>-MO and <italic>HtrA1</italic>-MO into a single dorsal blastomere and assessed the effects on NC cells. Importantly, knockdown of HtrA1 significantly reduced the EMT and migration defects in SerpinE2-depleted embryos (<xref rid="fig8" ref-type="fig">Figure 8D,D’,F,F’</xref>; see also Figure 8-figure supplement 1A,B). These epistatic experiments support the existence of an extracellular proteolytic regulatory system, in which SerpinE2 stimulates NC cell migration through the inhibition of HtrA1.</p>
<fig id="fig8" position="float" orientation="portrait" fig-type="figure">
<label>Figure 8.</label>
<caption><title>SerpinE2 functions in neural crest cell migration in an HtrA1- and Sdc4-dependent manner</title>
<p>mRNAs and morpholino oligonucleotides (MOs, 10 ng) were injected into one dorsal animal blastomere at the 8-cell stage. Embryos are shown in anterior view (stage 20, injected side labelled with a star, B-G) and lateral view (stage 26, B’-G’).</p>
<p><bold>(A)</bold> Proposed mechanism for the regulation of NC migration by SerpinE2, HtrA1 and Syndecan-4. <bold>(B-D’)</bold> <italic>SerpinE2</italic>-MO, blocks EMT and migration of <italic>Twist</italic><sup>+</sup> NC cells (arrow) on the injected side, while control-MO and <italic>SerpinE2</italic>-5MM<italic>-</italic>MO have no effect.</p>
<p><bold>(E-G’)</bold> <italic>Flag-SerpinE2</italic> mRNA, <italic>HtrA1</italic>-MO, and <italic>Sdc4</italic> mRNA restore normal NC migration in <italic>SerpinE2</italic>-morphant embryos.</p>
<p>Injected mRNA doses per embryos are 333 pg (<italic>Flag-SerpinE2</italic>) and 450 pg (<italic>Sdc4</italic>). For quantification of NC migration defects, see Figure 8-figure supplement 1A,B.</p></caption>
<graphic xlink:href="556243v2_fig8.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2j">
<title>HtrA1 and SerpinE2 regulate cranial neural crest migration via Syndecan-4</title>
<p>Syndecans comprise a family of single-pass transmembrane proteoglycans with four members in vertebrates (<xref ref-type="bibr" rid="c28">Keller-Pinter et al., 2021</xref>). Syndecan-4 (Sdc4) is a major component of focal adhesions and interacts with fibronectin during cell-matrix adhesion and cell movement (<xref ref-type="bibr" rid="c72">Woods and Couchman, 2001</xref>). We previously showed that HtrA1 triggers the proteolytic cleavage of Sdc4 and that SerpinE2 protects this proteoglycan from degradation by HtrA1 (<xref ref-type="bibr" rid="c25">Hou et al., 2007</xref>; <xref ref-type="bibr" rid="c1">Acosta et al., 2015</xref>). In <italic>Xenopus</italic> embryos, Sdc4 is abundant in the NC; knockdown of Sdc4 does not affect the induction of the NC but reduces its cell migration (<xref ref-type="bibr" rid="c38">Matthews et al., 2008</xref>). The effects of HtrA1 overexpression and SerpinE2 downregulation described in this study mimic the effects of Sdc4 depletion (<xref ref-type="bibr" rid="c38">Matthews et al., 2008</xref>). To investigate the relationship between the SerpinE2 and HtrA1 axis with Sdc4 in the NC we dorsally injected <italic>Sdc4</italic> mRNA and found it reduced in a concentration-dependent manner the EMT and NC migration defects induced by <italic>Flag-HtrA1</italic> mRNA (<xref rid="fig7" ref-type="fig">Figure 7C,C’,G,G’</xref>; see also Figure 7-figure supplement 1A,B). Ventral co-injection of <italic>Sdc4</italic> and <italic>Flag-HtrA1</italic> mRNAs was less efficient in rescuing NC cell migration (Figure 7-figure supplement 1C,D), because the transmembrane Sdc4 protein - unlike the secreted HtrA1 protease - remains anchored to ventral regions of the embryo and does not reach the dorsally located NC cells. Importantly, dorsally injected <italic>Sdc4</italic> mRNA partially restored normal EMT and cell migration in <italic>SerpinE2</italic>-morphant embryos (<xref rid="fig8" ref-type="fig">Figure 8D,D’,G,G’</xref>; see also Figure 8-figure supplement 1A,B). Therefore, our epistatic studies in <italic>Xenopus</italic> embryos suggest that SerpinE2 promotes NC cell migration by inhibiting HtrA1-mediated degradation of Syndecan-4.</p>
</sec>
</sec>
<sec id="s3">
<title>Discussion</title>
<p>This study reveals, for the first time, a role for the SerpinE2 and HtrA1 proteolytic pathway in embryonic cell migration. Several lines of evidence support the conclusion that this inhibitor/protease pair functionally interact in the control of NC cell motility. (1) SerpinE2 and HtrA1 were co-expressed in pre-migratory and migrating NC cells in the <italic>Xenopus</italic> embryo. (2) In gain-of-function studies, wild-type HtrA1, but not a protease-defective construct, inhibited NC migration and development of NC-derived structures, such as branchial arch cartilage, dorsal fin tissue, and melanocytes. (3) SerpinE2 reverted the HtrA1-induced migration defects in mRNA-injected embryos. (4) In loss-of-function studies, SerpinE2 knockdown inhibited NC migration and development of NC-derived structures. (5) Concomitant knockdown of SerpinE2 and HtrA1 restored normal NC migration in morpholino-oligonucleotide-injected embryos. Additional epistatic experiments showed that <italic>Sdc4</italic> mRNA partially rescues the migration defects induced by HtrA1 overexpression or SerpinE2 knockdown. Thus, SerpinE2, HtrA1 and Sdc4 form an important regulatory axis to control NC development. SerpinE2 promotes NC cell migration by inhibiting endogenous HtrA1 and preventing this protease from degrading the transmembrane proteoglycan Sdc4 in the <italic>Xenopus</italic> embryo. Hence, our study reveals a critical role for the SerpinE2-HtrA1-Sdc4 axis of extracellular proteins to regulate collective cell migration <italic>in vivo</italic> (<xref rid="fig8" ref-type="fig">Figure 8A</xref>).</p>
<sec id="s3a">
<title>Proteolytic control of morphogens</title>
<p>Secreted proteases, particularly of the astacin class of zinc metalloproteases are important for the formation of morphogen gradients. In Hydra, the HAS-7 protease normally processes Wnt3 and restricts head organizer formation; its knockdown results in ectopic organizers (<xref ref-type="bibr" rid="c74">Ziegler et al., 2021</xref>; <xref ref-type="bibr" rid="c23">Holstein, 2022</xref>). In <italic>Xenopus</italic>, Tolloid regulates Spemann’s organizer function by cleaving Chordin and de-repressing BMP signaling (<xref ref-type="bibr" rid="c52">Piccolo et al., 1997</xref>). The secreted Frizzled-related protein Sizzled binds to and inhibits Tolloid (<xref ref-type="bibr" rid="c34">Lee et al., 2006</xref>) and controls patterning of the dorsoventral axis through the following pathway:
<disp-quote><p>Sizzled ┤Tolloid protease ┤Chordin ┤ BMP</p></disp-quote></p>
<p>Our group previously showed that the serine protease HtrA1 induces mesoderm and ectopic tail formation by triggering the cleavage of Syndecan-4 and releasing active FGF messages (Hou et al., 2005). SerpinE2 (previously named protease nexin-1, PN1) binds to and inhibits HtrA1 (<xref ref-type="bibr" rid="c1">Acosta et al., 2015</xref>) and controls germ layer formation and patterning of the anteroposterior axis as follows:
<disp-quote><p>SerpinE2 ┤HtrA1 protease ┤Syndecan-4 ┤ FGF</p></disp-quote></p>
</sec>
<sec id="s3b">
<title>Extracellular proteases in cell migration</title>
<p>Migrating NC cells face major challenges to overcome physical barriers, such as the basal membrane or the extracellular matrix, suggesting proteolysis as an important mechanism for these cells to invade other tissues and reach their destined targets in the embryo. Matrix metalloproteases have been well-studied in extracellular matrix remodeling during NC development (<xref ref-type="bibr" rid="c19">Gouignard et al., 2018</xref>). Less understood are other classes of proteases in the control of NC cell migration and invasion. The laboratory of Nicole Le Douarin was first to show that migrating NC cells produce serine proteases (<xref ref-type="bibr" rid="c69">Valinsky and Le Douarin, 1985</xref>). Using interspecific quail-chick grafting and enzyme-specific zymography, the group demonstrated high plasminogen activator activity in lysates of cranial NC compared to adjacent embryonic tissues.</p>
<p>Subsequent studies by other laboratories showed that mouse NC cells secrete urokinase and tissue plasminogen activators (uPA and tPA) into the culture medium (<xref ref-type="bibr" rid="c40">Menoud et al., 1989</xref>) and that uPA promotes chick NC migration <italic>in vitro</italic> via activation of plasmin and TGFβ signaling (<xref ref-type="bibr" rid="c9">Brauer and Yee, 1993</xref>; <xref ref-type="bibr" rid="c2">Agrawal and Brauer, 1996</xref>). Mutations in the lectin complement pathway gene MASP1/3, encoding for Mannose-associated serine protease-1 and −3, cause 3MC (Mingarelli, Malpuech, Michels and Carnevale) syndrome, a rare autosomal recessive disorder that is characterized by a spectrum of developmental features including craniofacial abnormalities (<xref ref-type="bibr" rid="c53">Rooryck et al., 2011</xref>). Zebrafish morphants exhibit craniofacial cartilage and pigment defects as well as abnormal NC migration, suggesting that MASP1 is a guidance cue that directs the migration of NC cells in the early embryo. Of note, all secreted serine proteases listed above have a positive role in NC migration. As we now demonstrate, HtrA1 is the only serine protease identified so far that acts as a negative regulator of NC migration.</p>
<p>SerpinE2 has a broad spectrum of target serine proteases that it binds to and inhibits, including uPA, tPA and plasmin (<xref ref-type="bibr" rid="c6">Arocas and Bouton, 2015</xref>). Given the pro-migratory properties of these serine proteases, one should expect that SerpinE2 would inhibit NC migration by antagonizing their activity. However, overexpression of <italic>SerpinE2</italic> at mRNA doses of up to 4 ng did not affect the migration of NC cells in the <italic>Xenopus</italic> embryo. Instead, knockdown by morpholino oligonucleotides that block endogenous SerpinE2 protein biosynthesis (<xref ref-type="bibr" rid="c1">Acosta et al., 2015</xref>), efficiently inhibited NC migration and the development of NC-derived structures, as shown in this study. The finding that microinjection of <italic>SerpinE2</italic> mRNA reverted migration defects in these morphant embryos supports the view that SerpinE2 specifically promotes NC migration. It therefore appears that uPA, tPA and plasmin are not target proteases of SerpinE2 in the modulation of NC migration in the <italic>Xenopus</italic> embryo.</p>
</sec>
<sec id="s3c">
<title>SerpinE2 and HtrA1 form a proteolytic pathway in neural crest migration</title>
<p>In <italic>Xenopus</italic> embryos at the neurula stage, <italic>HtrA1</italic> transcripts were most abundant in the superficial (ependymal) layer of the ectoderm containing non-motile epithelial cells, whereas <italic>SerpinE2</italic> expression was confined to the deep (sensorial) layer of the ectoderm that gives rise to motile mesenchymal NC cells (<xref rid="fig1" ref-type="fig">Figure 1G</xref>). In post-neurula embryos, transcripts of these genes appeared in the collective of migrating NC cells, with <italic>SerpinE2</italic> accumulating near the front of the cell streams and <italic>HtrA1</italic> being enriched at their rear ends (<xref rid="fig1" ref-type="fig">Figure 1H</xref>). We propose that only in regions where the SerpinE2 concentration is sufficiently high, HtrA1-mediated repression of cell motility is relieved so that NC cell migration can occur. In support of this conclusion, microinjection of <italic>HtrA1</italic> mRNA reduced in a concentration-dependent manner EMT and migration of NC cells, leading to defects in craniofacial skeleton structures. A key experiment was that EMT and migration of NC cells were restored by HtrA1 knockdown in SerpinE2-depleted embryos, suggesting that SerpinE2 promotes NC migration via inhibiting endogenous HtrA1 protease activity in the embryo. Our finding that <italic>HtrA1</italic> mRNA and <italic>SerpinE2</italic>-MO diminished cell migration in isolated NC explants provided evidence that the two proteins act in a NC-autonomous manner. HtrA1 overexpression and SerpinE2 knockdown also reduced <italic>Sox9</italic>-expressing chondrogenic precursors in the NC-derived head mesenchyme and caused defects in the cartilaginous skull and hyobranchial skeleton in <italic>Xenopus</italic> tadpoles. Interestingly, increased <italic>HtrA1</italic> expression has been detected in cranial sutures of mice with thyroid hormone-induced craniofacial disruptions (<xref ref-type="bibr" rid="c26">Howie et al., 2016</xref>). Since proper migration of NC cells is essential for the formation of bones, cartilage and soft tissue in the head (<xref ref-type="bibr" rid="c41">Minoux and Rijli, 2010</xref>), elevated HtrA1 levels might disturb NC migration not only in <italic>Xenopus</italic>, but also in mammalian embryos.</p>
</sec>
<sec id="s3d">
<title>SerpinE2 and HtrA1 regulate neural crest migration as extracellular proteins</title>
<p>The expression patterns were consistent with loss- and gain-of-function data that SerpinE2 promoted EMT and NC cell migration, whereas HtrA1 had the opposite effect. The actin cytoskeleton and microtubules play important roles in cell migration (<xref ref-type="bibr" rid="c58">Seetharaman and Etienne-Manneville, 2020</xref>). Two cytoskeletal proteins with functions in cell movement, i.e. fascin (actin bundling) and talin1 (regulation of actin assembly in focal adhesions), were previously identified as proteolytic substrates of HtrA1 (<xref ref-type="bibr" rid="c5">An et al., 2010</xref>). It has also been shown that the protease cleaves tubulins (<xref ref-type="bibr" rid="c12">Chien et al., 2009a</xref>) and that HtrA1 binds to and stabilizes microtubules via its PDZ domain (<xref ref-type="bibr" rid="c13">Chien et al., 2009b</xref>). However, the significance of the degradation of cytoskeletal proteins by HtrA1 remains unclear and it is unknown whether the association between HtrA1 and microtubules is important for cell motility. Here we showed that wild-type HtrA1, but not a derived construct that was lacking a secretory signal peptide (HtrA1ΔSP), inhibited NC migration as well as craniofacial, dorsal fin, and melanocyte development. An HtrA1 construct with a deletion of the PDZ domain (HtrA1ΔPDZ) efficiently reduced EMT and migration of NC cells. The results strongly suggest that HtrA1 acts primarily as an extracellular protease during NC collective cell migration.</p>
<p>SerpinE2 shares with other members of the Serpin family a reactive center loop (RCL) that is cleaved by target proteases at the process site and forms a covalent acyl-enzyme complex leading to irreversible inhibition of the protease (<xref ref-type="bibr" rid="c45">Olson and Gettins, 2011</xref>; <xref ref-type="bibr" rid="c6">Arocas and Bouton, 2015</xref>). The introduction of prolines to residues P1 and P1’ at the RCL cleavage site reduces the ability of SerpinE2 to physically interact with the catalytic trypsin domain of HtrA1 and inhibits its protease activity (<xref ref-type="bibr" rid="c1">Acosta et al., 2015</xref>). Here we demonstrated that wild-type SerpinE2 restored normal EMT and migration of NC cells in <italic>HtrA1</italic> mRNA-injected embryos, whereas a point mutant SerpinE2 construct with the mutations Arg362Pro and Ser363Pro at P1 and P1’ of the scissile site (SerpinE2pm) failed to show any effect. In addition, a SerpinE2 construct without a secretory signal peptide (SerpinE2ΔSP) did not revert the HtrA1-induced NC migration defects. The results underscore that SerpinE2 promotes NC migration as an extracellular protease inhibitor.</p>
</sec>
<sec id="s3e">
<title>The SerpinE2-HtrA1-Syndecan-4 axis functions in neural crest migration</title>
<p>Syndecan-4 (Sdc4) is a central component of focal adhesion complexes that regulate cell-matrix adhesion and cell migration in cooperation with members of the integrin family of transmembrane proteins (<xref ref-type="bibr" rid="c28">Keller-Pinter et al., 2021</xref>). In zebrafish and <italic>Xenopus</italic> embryos, Sdc4 is expressed in migrating NC cells and promotes directional NC cell migration via regulation of the small GTPase Rac1 and activation of non-canonical Wnt signaling in the planar cell polarity pathway (<xref ref-type="bibr" rid="c38">Matthews et al. 2008</xref>). Similarly, human SDC4 favors cell migration and invasion through activation of Wnt5A signals in melanoma (<xref ref-type="bibr" rid="c44">O’Connell et al., 2009</xref>), indicating conserved signaling downstream of this proteoglycan in NC cell migration and malignant progression of a NC-derived cancer.</p>
<p>Several metalloproteases (MMP-3, −9 and −14) and serine proteases (plasmin, thrombin) cleave Sdc4 preferentially at the juxtamembrane site, so that its ectodomain can be released from the cell surface (<xref ref-type="bibr" rid="c36">Manon-Jensen et al., 2013</xref>). We previously showed that HtrA1 triggers the proteolytic cleavage of <italic>Xenopus</italic> Sdc4 (<xref ref-type="bibr" rid="c25">Hou et al., 2007</xref>). Whether HtrA1 directly cleaves this transmembrane protein or induces its cleavage through activation of other proteases remains to be shown. We further reported that SerpinE2 through physical interaction prevents HtrA1-mediated Sdc4 degradation, and that endogenous SerpinE2 is needed to protect the integrity of Sdc4 in embryos (<xref ref-type="bibr" rid="c1">Acosta et al., 2015</xref>). Here we showed that <italic>Sdc4</italic> mRNA rescued NC migration defects that were induced by co-injection of <italic>HtrA1</italic> mRNA, indicating that Sdc4 is a relevant target of HtrA1 <italic>in vivo</italic>. The finding that <italic>Sdc4</italic> mRNA also rescued migration defects in <italic>SerpinE2</italic>-morphant embryos suggests a proteolytic pathway by the following double inhibition mechanism:
<disp-quote><p>SerpinE2 ┤HtrA1 protease ┤Syndecan-4 → NC cell migration</p></disp-quote></p>
</sec>
<sec id="s3f">
<title>SerpinE2 and HtrA1 might modulate FGF signals in directed neural crest migration</title>
<p>FGF signals including FGF8 stimulate NC migration by increasing cell motility and guiding cell movement (<xref ref-type="bibr" rid="c30">Kubota and Ito, 2000</xref>; <xref ref-type="bibr" rid="c56">Sato et al., 2011</xref>). In <italic>Xenopus</italic> embryos, the target tissues of NC streams secrete FGF8 and other FGF ligands, while the migrating NC cells express FGF receptors, including FGFR1 and FGFR4 (<xref ref-type="bibr" rid="c8">Brändli and Kirschner, 1995</xref>; <xref ref-type="bibr" rid="c32">Lea et al., 2009</xref>). Once released from the cells, FGFs are bound by heparan sulfate (HS) chains of cell surface proteoglycans such as the transmembrane Sdc4, which limit their diffusion (<xref ref-type="bibr" rid="c37">Matsuo and Kimura-Yoshida, 2013</xref>). We previously reported that the HtrA1-mediated proteolytic cleavage of Sdc4 mobilizes FGFs complexed to its soluble ectodomain, allowing these FGF-proteoglycan messages to activate FGFRs at distance (<xref ref-type="bibr" rid="c25">Hou et al., 2007</xref>). HS protects FGFs against cleavage by serine proteases (<xref ref-type="bibr" rid="c55">Saksela et al., 1988</xref>, <xref ref-type="bibr" rid="c61">Sommer and Rifkin, 1989</xref>), and HtrA1 can degrade free FGF8 protein (<xref ref-type="bibr" rid="c29">Kim et al., 2012</xref>). We showed that the HtrA1 inhibitor SerpinE2 stabilizes Sdc4 and regulates long-range FGF signaling in the <italic>Xenopus</italic> embryo (<xref ref-type="bibr" rid="c1">Acosta et al., 2015</xref>). The expression data presented here suggest that opposing gradients of SerpinE2 and HtrA1 form in the collective of migrating NC cells (<xref rid="fig1" ref-type="fig">Figure 1H</xref>). By controlling the mobilization of FGF signals, the SerpinE2-HtrA1 pair might help to establish a chemotactic FGF gradient and thereby facilitate collective migration of NC cells (<xref rid="fig9" ref-type="fig">Figure 9B</xref>).</p>
<fig id="fig9" position="float" orientation="portrait" fig-type="figure">
<label>Figure 9.</label>
<caption><title>Model for a proteolytic pathway of SerpinE2 and HtrA1 that regulates collective neural crest migration</title>
<p><bold>(A)</bold> SerpinE2 stimulates collective NC migration by a double-inhibitory mechanism involving the secreted serine protease HtrA1 and its proteolytic substrates Syndecan-4 and Fibronectin.</p>
<p><bold>(B)</bold> Opposing gradients of SerpinE2 and HtrA1 activities regulate the directed migration in a collective of NC cells. The SerpinE2/HtrA1 pair contributes to the formation of a chemoattractant gradient that guides the NC stream towards a source of FGF signals in the target tissue. High SerpinE2 and low HtrA1 levels coincide with abundant focal adhesion sites and polymerized actin that drive mesenchymal migration at the leading edge.</p>
<p><bold>(C)</bold> SerpinE2 anchored to the heparan sulfate chains of the transmembrane proteoglycan Syndecan-4 protects the integrity of focal adhesions at the leading front and allows collective cell migration to occur (left side). Unbound HtrA1 triggers the proteolytic cleavage of Syndecan-4 and degrades the matrix protein Fibronectin (middle), causing loss of cell-matrix adhesion at the rear end of the NC cell collective (right side).</p>
<p>FGF, fibroblast growth factor; HS, heparan sulfate; NC, neural crest; Sdc4, Syndecan-4.</p></caption>
<graphic xlink:href="556243v2_fig9.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s3g">
<title>Fibronectin is a possible target of the SerpinE2-HtrA1 axis in neural crest cell adhesion and migration</title>
<p>Binding of fibronectin to the HS chains of Sdc4 and to the extracellular domain of the integrin adhesion receptors is critical for the activation of intracellular signaling that affects actin polymerization and contraction (<xref ref-type="bibr" rid="c28">Keller-Pinter et al., 2021</xref>). Fibronectin is ubiquitously expressed along NC migration pathways in the <italic>Xenopus</italic> embryo (<xref ref-type="bibr" rid="c15">Davidson et al., 2004</xref>). This glycoprotein is the only known extracellular matrix component that promotes <italic>Xenopus</italic> cranial NC cell migration as an adhesive substrate (<xref ref-type="bibr" rid="c4">Alfandari et al., 2003</xref>). Our study showed that HtrA1 overexpression and SerpinE2 knockdown reduced adhesion of cranial NC cells to fibronectin <italic>in vitro</italic>. Since fibronectin is a proteolytic substrate of HtrA1 (<xref ref-type="bibr" rid="c20">Grau et al., 2006</xref>; <xref ref-type="bibr" rid="c21">Hadfield et al., 2008</xref>), degradation of this matrix component might contribute to the HtrA1-mediated inhibition of NC migration.</p>
</sec>
<sec id="s3h">
<title>A gradient of serine protease activity may act in collective NC migration</title>
<p>We are proposing a mechanism, in which SerpinE2 and HtrA1 constitute a proteolytic pathway that regulates collective NC migration by targeting the focal adhesion protein Sdc4 and the matrix protein fibronectin (<xref rid="fig9" ref-type="fig">Figure 9A</xref>). Our structure-function analyses and epistatic experiments led us suggest a model in which SerpinE2 and HtrA1 regulate directed migration of the NC collective via remodeling of cell-matrix adhesions (<xref rid="fig9" ref-type="fig">Figure 9C</xref>). Since SerpinE2 has a high affinity for HS through its heparin binding domain (<xref ref-type="bibr" rid="c35">Li and Huntington, 2012</xref>), the transmembrane Sdc4 proteoglycan likely recruits this protease inhibitor to the pericellular space. Elevated SerpinE2 concentration keeps HtrA1 activity low near the leading edge of the NC collective; this protects the integrity of both Sdc4 and fibronectin in focal adhesions, which is critical for the leader cells to attach to the matrix and drive cell migration (left side in <xref rid="fig9" ref-type="fig">Figure 9C</xref>). Gradually decreasing SerpinE2 protein levels and a concomitant increase in HtrA1 protease activity behind the leader cells triggers degradation of Sdc4 and cleavage of fibronectin, causing disruption of focal adhesion complexes in follower cells and loss of cell-matrix binding at the rear end of the NC cluster (right side in <xref rid="fig9" ref-type="fig">Figure 9C</xref>).</p>
</sec>
<sec id="s3i">
<title>SERPINE2, HTRA1 and SDC4 might interact in human placenta development and pre-eclampsia</title>
<p>An interaction of SerpinE2, HtrA1 and Sdc4 in cell migration might not be confined to the NC as shown in this study but could also occur in other aspects of development and disease. In the developing placenta, extravillous trophoblast (EVT) cells from the human embryo migrate into the inner uterus wall (endometrium) and invade the uterine spiral arteries, converting them into large blood vessels so that the blood flow to the embryo is enhanced. Inadequate EVT migration results in insufficient maternal artery remodeling, causing hypoxia of the placenta and hypertension in a pathological condition called pre-eclampsia that is potentially life-threatening for both fetus and mother. The placenta expresses the highest levels of SERPINE2 among all probed human tissues (The Human Protein Atlas; <ext-link ext-link-type="uri" xlink:href="https://www.proteinatlas.org/">https://www.proteinatlas.org/</ext-link>), with abundant protein expression in migratory EVTs and spiral arteries (<xref ref-type="bibr" rid="c11">Chern et al., 2011</xref>). HTRA1 expression is low in EVTs, high in less motile villous trophoblasts and upregulated in the placenta of patients with pre-eclampsia (<xref ref-type="bibr" rid="c3">Ajayi et al., 2008</xref>). Interestingly, the migration and invasion of cultured EVTs is inhibited by silencing of SERPINE2 (<xref ref-type="bibr" rid="c11">Chern et al., 2011</xref>), overexpression of HTRA1 (<xref ref-type="bibr" rid="c3">Ajayi et al., 2008</xref>) and knockdown of SDC4 (<xref ref-type="bibr" rid="c27">Jeyarajah et al., 2019</xref>). The results suggest that the SERPINE2-HTRA1-SDC4 axis might regulate trophoblast motility during placental development and a serious pregnancy condition in humans.</p>
</sec>
<sec id="s3j">
<title>The SERPINE2-HTRA1-SDC4 regulatory axis might act in cancer</title>
<p>Cell migration is a hallmark of tumor malignancy and essential for metastasis formation (<xref ref-type="bibr" rid="c22">Hanahan and Weinberg, 2011</xref>). SERPINE2 is upregulated in aggressive variants of several cancer types, and high expression levels correlate with poor prognosis in patients (<xref ref-type="bibr" rid="c6">Arocas and Bouton, 2015</xref>). Downregulation of SERPINE2 impairs the metastatic spread of melanoma and breast cancer cells in xenografted mice (<xref ref-type="bibr" rid="c70">Wagenblast et al., 2015</xref>; <xref ref-type="bibr" rid="c73">Wu et al., 2016</xref>; <xref ref-type="bibr" rid="c66">Tang et al., 2019</xref>), suggesting a positive role of SERPINE2 in cancer cell migration and metastasis. On the other hand, HTRA1 is downregulated in many primary tumors and metastatic foci, while low levels correlate with poor clinical outcome (<xref ref-type="bibr" rid="c75">Zurawa-Janicka et al., 2017</xref>). Overexpression of HTRA1 inhibits the invasion and migration of melanoma and breast cancer cells, respectively (<xref ref-type="bibr" rid="c7">Baldi et al., 2002</xref>; <xref ref-type="bibr" rid="c71">Wang et al., 2012</xref>). SDC4 is overexpressed in several tumor types such as melanoma, and high expression levels are associated with poor prognosis in breast cancer (<xref ref-type="bibr" rid="c28">Keller-Pinter et al., 2021</xref>). Gene silencing confirms the requirement of SDC4 in the metastasis of human breast carcinoma cells in mice (<xref ref-type="bibr" rid="c33">Leblanc et al. 2018</xref>). Together, the double-inhibitory mechanism involving the molecular interaction of SERPINE2, HTRA1 and SDC4 as suggested here for NC cell migration in the <italic>Xenopus</italic> embryo might also regulate cancer cell migration in human metastasis.</p>
</sec>
</sec>
<sec id="s4">
<title>Conclusions</title>
<p>This is the first study to demonstrate an interaction of SerpinE2 and HtrA1 in cell migration <italic>in vivo</italic>. We showed that SerpinE2 and HtrA1 acted in the extracellular space at least partly through the cell surface proteoglycan Sdc4 to govern NC migration in <italic>Xenopus</italic> embryos. The secreted SerpinE2 and HtrA1 proteins, as well as the ectodomain of Sdc4, are amenable to neutralizing antibodies. Our structure-function analysis unraveled important roles for the RCL of SerpinE2 and the catalytic serine residue of its target protease, whereas the PDZ domain of HtrA1 was not involved in the control of NC cell migration. The identification of critical domains in SerpinE2 and HtrA1 provides an important basis for the development of effective therapeutics in craniofacial anomalies and other neurocristopathies. Given the roles of these proteins in trophoblast migration in the developing placenta, together with their implication in metastasis of numerous tumor types, the SERPINE2-HTRA1-SDC4 axis constitutes a potential therapeutic target for the treatment of pre-eclampsia and various aggressive cancers.</p>
</sec>
<sec id="s5">
<title>Materials and Methods</title>
<sec id="s5a">
<title>Key Resources Table</title>
<table-wrap id="utbl1" orientation="portrait" position="float">
<graphic xlink:href="556243v2_utbl1.tif" mimetype="image" mime-subtype="tiff"/>
<graphic xlink:href="556243v2_utbl1a.tif" mimetype="image" mime-subtype="tiff"/>
<graphic xlink:href="556243v2_utbl1b.tif" mimetype="image" mime-subtype="tiff"/>
<graphic xlink:href="556243v2_utbl1c.tif" mimetype="image" mime-subtype="tiff"/>
</table-wrap>
</sec>
<sec id="s5b">
<title>Materials availability statement</title>
<p>Requests for resources and further information should be directed and will be fulfilled by the corresponding author, Edgar M. Pera.</p>
</sec>
<sec id="s5c">
<title>Constructs</title>
<p>pCS2-<italic>Flag-HtrA1</italic> (identical with pCS2-<italic>xHtrA1*</italic>; <xref ref-type="bibr" rid="c25">Hou et al., 2007</xref>) and pCS2-<italic>Flag-SerpinE2</italic> (identical with pCS2-<italic>Flag-PN1</italic>; <xref ref-type="bibr" rid="c1">Acosta et al., 2015</xref>) were previously described. Briefly, N-terminally truncated open reading frames of <italic>Xenopus laevis</italic> HtrA1.S (amino acids 17-459) and SerpinE2.L (amino acids 20-395) were each introduced into a modified pCS2 expression vector in frame and downstream of a secretion cassette with the sequence <underline>MQCPPILLVWTLWIMAVDC</underline>SRPKVFLPIQPEQEPLQSKT(DYKDDDDK)LE that contains a cleavable signal peptide (underlined) and N-terminus until Thr39 of <italic>Xenopus laevis</italic> Chordin, followed by a Flag-tag (in brackets) and two amino acids (LE) representing an <italic>Xho</italic>I cloning site (pCS2-Chd<italic>SP-Flag</italic>, constructed by Stefano Piccolo in the laboratory of Eddy De Robertis, UCLA). Using pCS2-<italic>Flag-HtrA1</italic> and pCS2-<italic>Flag-SerpinE2</italic> as templates, the N-bterminally truncated open reading frames of HtrA1 and SerpinE2 were PCR-amplified, using a forward primer that inserts a start codon before the N-terminal Flag-tag, and subcloned into the expression vector pCS2 to generate pCS2-<italic>Flag-HtrA1ΔSP</italic> and pCS2-<italic>Flag-SerpinE2ΔSP</italic>. The PCR reactions were performed with high fidelity <italic>Pfu</italic> DNA polymerase (Thermo Fisher, EP0572), and correct sequences were validated by sequencing in sense and antisense directions (Eurofins, Germany). Protein bands were quantified using Image Lab (BioRad).</p>
</sec>
<sec id="s5d">
<title>Antisense morpholino oligonucleotides</title>
<p>(purchased from Gene Tools LLC.)</p>
<table-wrap id="utbl2" orientation="portrait" position="float">
<graphic xlink:href="556243v2_utbl2.tif" mimetype="image" mime-subtype="tiff"/>
</table-wrap>
</sec>
<sec id="s5e">
<title><italic>Xenopus</italic> embryo microinjection</title>
<p>To prepare mRNA, pCS2 constructs containing <italic>HtrA1</italic>, <italic>HtrA1-S307A</italic>, and <italic>Flag-HtrA1</italic> (<xref ref-type="bibr" rid="c25">Hou et al., 2007</xref>), <italic>HtrA1-myc</italic>, <italic>HtrA111PDZ-myc, Flag-SerpinE2</italic> and <italic>Flag-SerpinE2pm</italic> (<xref ref-type="bibr" rid="c1">Acosta et al., 2015</xref>), <italic>Flag-HtrA1ΔSP</italic> and <italic>Flag-SerpinE2ΔSP</italic> (this study), <italic>nlacZ</italic> (a kind gift from Dr. Tomas Pieler, University Göttingen, Germany), <italic>eGFP</italic> (a kind gift from Dr. Eric Bellefroid, Université Libre de Bruxelles, Belgium) and <italic>Flag-Sdc4</italic> (Muñoz et al., 2006) were linearized with NotI and transcribed with Sp6 RNA polymerase (mMessage mMachine<sup>TM</sup>, Invitrogen). Embryos were injected in 1xMBS (Modified Barth’s saline) and cultured in 0,1X MBS. Pigmented embryos were injected into all four animal blastomeres at the 8-cell stage. Albino embryos were injected into a single animal blastomere with <italic>nlacZ</italic> mRNA as a lineage tracer and stained with Magenta-Red (Sigma B8931, red nuclei) after fixation. Dorsally and ventrally injected embryos were identified based on the lineage tracer pattern. Embryos were prepared, fixed and processed by whole-mount <italic>in situ</italic> hybridization as described (<xref ref-type="bibr" rid="c50">Pera et al., 2015</xref>).</p>
</sec>
<sec id="s5f">
<title>Neural crest explantation, <italic>in vitro</italic> culture and time-lapse imaging</title>
<p>For NC extirpation, the vitelline membrane was removed with fine forceps from pigmented embryos at stage 17 and the neural folds were extracted in 1xMMR (Marc’s Minimal Ringers) buffer, using eye lashes mounted with nail polisher to pipet tips. Operated embryos were cultured in 0,3xMMR and 50 ug/ml Gentamycin (Sigma G1272) until stage 41.</p>
<p>CNC explants and single fluorescently labelled cells from <italic>eGFP</italic> mRNA-injected embryos were cultured in Danilchik’s for Amy media (53 mM NaCl, 5 mM Na<sub>2</sub>CO<sub>3</sub>, 4.5 K gluconate, 32 mM Na gluconate, 1 mM MgSO<sub>4</sub>, 1 mM CaCl<sub>2</sub>, 0.1% bovine serum albumine, adjusted with 1 M bicine to pH 8.3) in fibronectin-coated plastic dishes as described (<xref ref-type="bibr" rid="c18">Gouignard et al., 2016</xref>).</p>
<p>For video time-lapse imaging, CNC explants were cultured in 23% Leibovitz’s L15 medium in fibronectin-coated glass-bottom culture dishes (MatTek Corp. P35G-0-10-C). The video was taken after 7 hours in culture. Filming was done with a Zeiss inverted microscope, and AxioVision 4.8.2 SP3 software was used for imaging.</p>
</sec>
<sec id="s5g">
<title>Cell culture and transfection</title>
<p>HEK293T cells were cultured in DMEM (Dulbecco’s modified Eagle medium) supplemented with 10% heat-inactivated fetal bovine serum (FBS) and penicillin/streptavidin. The cells were seeded at a density of 20-30% in Opti-MEM (Thermo Fisher Scientific) with penicillin/streptavidin in 6-well plates, and transient transfection with plasmid DNAs was performed using Lipofectamin 3000 (Thermo Fisher Scientific), when cells reached between 60-70% confluency. Following a medium exchange 6 hours after transfection, the supernatant was harvested, and the cells were lysed 70 hours after transfection.</p>
</sec>
<sec id="s5h">
<title>Sample preparations and Western blotting</title>
<p>Microinjected embryos and transfected HEK293T cells were lysed using RIPA-buffer (Thermo Fisher Scientific, Cat# 89901) supplemented with protease/phosphatase inhibitor cocktail (Thermo Fisher Scientific, Cat# 78442). The cell lysate was sonicated, using the Sonicator Bioruptor Plus (Diagenode) with 40 cycles for 15 seconds on and 15 seconds off. The supernatant was cleared from cells by centrifugations first at 2500 rpm and then at 8000 rpm for each 5 minutes at 4°C. After addition of a protease inhibitor cocktail (Roche, Cat#11873580001), proteins in the supernatant were concentrated, using Vivaspin2 10kDa molecular weight cut-off columns (Cytiva, Cat# 28932247). Proteins were measured in the lysates and supernatants, using the Pierce BCA Protein assay kit (Thermo Fisher Scientific, Cat# 23225). Gel electrophoresis was performed with 20 μg protein per lane, using Bolt Bis-Tris Plus Mini Protein gels (4-12%, Thermo Fisher Scientific, Cat# NW04125BOX). Western blots were performed, using the following primary antibodies: anti-flag HRP-conjugated (1:1000; Sigma-Aldrich, A8592), anti-αTubulin (1:1000; Sigma-Aldrich, T5168), anti-φ3Actin (1:10,000; Sigma-Aldrich, A5441), immunopurified anti-HtrA1 (5 μg/ml; <xref ref-type="bibr" rid="c25">Hou et al., 2007</xref>).</p>
</sec>
<sec id="s5i">
<title>Statistical analysis</title>
<p>Results are shown as mean ± standard deviation (SD). Unpaired t-test was employed for comparing means of two treatment groups. For multiple comparisons, one-way ANOVA followed by Tukey’s post hoc test was used. Statistical significance was defined as **p&lt;0,01, ***p&lt;0,001 and ****p&lt;0,0001.</p>
</sec>
</sec>
<sec id="d1e2115" sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material id="d1e2232">
<label>Supplementary Material</label>
<media xlink:href="supplements/556243_file03.pdf"/>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We are indebted to Drs. E. Bellefroid, E. M. De Robertis, J. Larraine, J.-P. Saint Jeannet, and T. Pieler for plasmids, to Drs. Erika Velásquez, Isak Martinsson, Oxana Klementieva, Gunnar Gouras for sharing advice and equipment, and to J. Monka for comments on the manuscript.</p>
</ack>
<sec id="s6">
<title>Funding information</title>
<p>This paper was supported by the following grants:</p>
<p>Swedish Research Council 2009-4951 to Edgar M. Pera</p>
<p>Swedish Childhood Cancer Fund PROJ11/101 to Edgar M. Pera</p>
<p>O.E. and Edla Johansson foundation to Edgar M. Pera</p>
<p>Albert Påhlsson foundation to Edgar M. Pera</p>
<p>Pia Ståhl foundation to Edgar M. Pera</p>
<p>MultiPark to Laurent Roybon</p>
<p>Swedish Research Council 2021-02284 to Laurent Roybon</p>
<p>The funders had no role in the study design, data collection, and interpretation, or the decision to submit the work for publication.</p>
</sec>
<sec id="s7">
<title>Ethics</title>
<p>This study was conducted in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All <italic>Xenopus laevis</italic> experiments reported in this study were approved by the Lund/Malmö regional ethical committee (Dnr. 5.8.18-15884/2019).</p>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><mixed-citation publication-type="journal"><string-name><surname>Acosta</surname> <given-names>H</given-names></string-name>, <string-name><surname>Iliev</surname> <given-names>D</given-names></string-name>, <string-name><surname>Grahn</surname> <given-names>TH</given-names></string-name>, <etal>et al.</etal> <article-title>The serpin PN1 is a feedback regulator of FGF signaling in germ layer and primary axis formation</article-title>. <source>Development</source>. <year>2015</year>;<volume>142</volume>(<issue>6</issue>):<fpage>1146</fpage>–<lpage>1158</lpage>. doi:<pub-id pub-id-type="doi">10.1242/dev.113886</pub-id>.</mixed-citation></ref>
<ref id="c2"><mixed-citation publication-type="journal"><string-name><surname>Agrawal</surname> <given-names>M</given-names></string-name>, <string-name><surname>Brauer</surname> <given-names>PR</given-names></string-name>. <article-title>Urokinase-type plasminogen activator regulates cranial neural crest cell migration in vitro</article-title>. <source>Dev Dyn</source>. <year>1996</year>;<volume>207</volume>(<issue>3</issue>):<fpage>281</fpage>–<lpage>290</lpage>. doi:<pub-id pub-id-type="doi">10.1002/(SICI)1097-0177(199611)207:3</pub-id>&lt;281::AID-AJA5&gt;3.0.CO;2-D.</mixed-citation></ref>
<ref id="c3"><mixed-citation publication-type="journal"><string-name><surname>Ajayi</surname> <given-names>F</given-names></string-name>, <string-name><surname>Kongoasa</surname> <given-names>N</given-names></string-name>, <string-name><surname>Gaffey</surname> <given-names>T</given-names></string-name>, <string-name><surname>Asmann</surname> <given-names>YW</given-names></string-name>, <string-name><surname>Watson</surname> <given-names>WJ</given-names></string-name>, <string-name><surname>Baldi</surname> <given-names>A</given-names></string-name>, <string-name><surname>Lala</surname> <given-names>P</given-names></string-name>, <string-name><surname>Shridhar</surname> <given-names>V</given-names></string-name>, <string-name><surname>Brost</surname> <given-names>B</given-names></string-name>, <string-name><surname>Chien</surname> <given-names>J</given-names></string-name>. <article-title>Elevated expression of serine protease HtrA1 in preeclampsia and its role in trophoblast cell migration and invasion</article-title>. <source>Am J Obstet Gynecol</source>. <year>2008</year>;<volume>199</volume>(<issue>5</issue>):<fpage>557</fpage>.e1-10. doi: <pub-id pub-id-type="doi">10.1016/j.ajog.2008.04.046</pub-id>.</mixed-citation></ref>
<ref id="c4"><mixed-citation publication-type="journal"><string-name><surname>Alfandari</surname> <given-names>D</given-names></string-name>, <string-name><surname>Cousin</surname> <given-names>H</given-names></string-name>, <string-name><surname>Gaultier</surname> <given-names>A</given-names></string-name>, <string-name><surname>Hoffstrom</surname> <given-names>BG</given-names></string-name>, <string-name><surname>DeSimone</surname> <given-names>DW</given-names></string-name>. <article-title>Integrin alpha5beta1 supports the migration of Xenopus cranial neural crest on fibronectin</article-title>. <source>Dev Biol</source>. <year>2003</year>;<volume>260</volume>(<issue>2</issue>):<fpage>449</fpage>–<lpage>464</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s0012-1606(03)00277-x</pub-id>.</mixed-citation></ref>
<ref id="c5"><mixed-citation publication-type="journal"><string-name><surname>An</surname> <given-names>E</given-names></string-name>, <string-name><surname>Sen</surname> <given-names>S</given-names></string-name>, <string-name><surname>Park</surname> <given-names>SK</given-names></string-name>, <string-name><surname>Gordish-Dressman</surname> <given-names>H</given-names></string-name>, <string-name><surname>Hathout</surname> <given-names>Y</given-names></string-name>. <article-title>Identification of novel substrates for the serine protease HTRA1 in the human RPE secretome</article-title>. <source>Invest Ophthalmol Vis Sci</source>. <year>2010</year>;<volume>51</volume>(<issue>7</issue>):<fpage>3379</fpage>–<lpage>3386</lpage>. doi:<pub-id pub-id-type="doi">10.1167/iovs.09-4853</pub-id>.</mixed-citation></ref>
<ref id="c6"><mixed-citation publication-type="journal"><string-name><surname>Arocas</surname> <given-names>V</given-names></string-name>, <string-name><surname>Bouton</surname> <given-names>MC.</given-names></string-name> <article-title>Protease nexin-1: a serpin involved in pathophysiology</article-title>. <person-group person-group-type="editor"><string-name><given-names>M.</given-names> <surname>Geiger</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Wahlmüller</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Furtmüller</surname></string-name></person-group> (Eds.), <source>The Serpin Family, Springer International Publishing, Cham</source>. (<year>2015</year>), pp. <fpage>179</fpage>–<lpage>196</lpage>, <pub-id pub-id-type="doi">10.1007/978-3-319-22711-5_11</pub-id>.</mixed-citation></ref>
<ref id="c7"><mixed-citation publication-type="journal"><string-name><surname>Baldi</surname> <given-names>A</given-names></string-name>, <string-name><surname>De Luca</surname> <given-names>A</given-names></string-name>, <string-name><surname>Morini</surname> <given-names>M</given-names></string-name>, <string-name><surname>Battista</surname> <given-names>T</given-names></string-name>, <string-name><surname>Felsani</surname> <given-names>A</given-names></string-name>, <string-name><surname>Baldi</surname> <given-names>F</given-names></string-name>, <string-name><surname>Catricalà</surname> <given-names>C</given-names></string-name>, <string-name><surname>Amantea</surname> <given-names>A</given-names></string-name>, <string-name><surname>Noonan</surname> <given-names>DM</given-names></string-name>, <string-name><surname>Albini</surname> <given-names>A</given-names></string-name>, <string-name><surname>Natali</surname> <given-names>PG</given-names></string-name>, <string-name><surname>Lombardi</surname> <given-names>D</given-names></string-name>, <string-name><surname>Paggi</surname> <given-names>MG</given-names></string-name>. <article-title>The HtrA1 serine protease is down-regulated during human melanoma progression and represses growth of metastatic melanoma cells</article-title>. <source>Oncogene</source>. <year>2002</year>;<volume>21</volume>(<issue>43</issue>):<fpage>6684</fpage>–<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1038/sj.onc.1205911</pub-id>.</mixed-citation></ref>
<ref id="c8"><mixed-citation publication-type="journal"><string-name><surname>Brändli</surname> <given-names>AW</given-names></string-name>, <string-name><surname>Kirschner</surname> <given-names>MW</given-names></string-name>. <article-title>Molecular cloning of tyrosine kinases in the early Xenopus embryo: identification of Eck-related genes expressed in cranial neural crest cells of the second (hyoid) arch</article-title>. <source>Dev Dyn</source>. <year>1995</year>;<volume>203</volume>(<issue>2</issue>):<fpage>119</fpage>–<lpage>40</lpage>. doi: <pub-id pub-id-type="doi">10.1002/aja.1002030202</pub-id>.</mixed-citation></ref>
<ref id="c9"><mixed-citation publication-type="journal"><string-name><surname>Brauer</surname> <given-names>PR</given-names></string-name>, <string-name><surname>Yee</surname> <given-names>JA</given-names></string-name>. <article-title>Cranial neural crest cells synthesize and secrete a latent form of transforming growth factor beta that can be activated by neural crest cell proteolysis</article-title>. <source>Dev Biol</source>. <year>1993</year>;<volume>155</volume>(<issue>1</issue>):<fpage>281</fpage>–<lpage>285</lpage>. doi:<pub-id pub-id-type="doi">10.1006/dbio.1993.1026</pub-id>.</mixed-citation></ref>
<ref id="c10"><mixed-citation publication-type="journal"><string-name><surname>Campioni</surname> <given-names>M</given-names></string-name>, <string-name><surname>Severino</surname> <given-names>A</given-names></string-name>, <string-name><surname>Manente</surname> <given-names>L</given-names></string-name>, <string-name><surname>Tuduce</surname> <given-names>IL</given-names></string-name>, <string-name><surname>Toldo</surname> <given-names>S</given-names></string-name>, <string-name><surname>Caraglia</surname> <given-names>M</given-names></string-name>, <string-name><surname>Crispi</surname> <given-names>S</given-names></string-name>, <string-name><surname>Ehrmann</surname> <given-names>M</given-names></string-name>, <string-name><surname>He</surname> <given-names>X</given-names></string-name>, <string-name><surname>Maguire</surname> <given-names>J</given-names></string-name>, <string-name><surname>De Falco</surname> <given-names>M</given-names></string-name>, <string-name><surname>De Luca</surname> <given-names>A</given-names></string-name>, <string-name><surname>Shridhar</surname> <given-names>V</given-names></string-name>, <string-name><surname>Baldi</surname> <given-names>A</given-names></string-name>. <article-title>The serine protease HtrA1 specifically interacts and degrades the tuberous sclerosis complex 2 protein</article-title>. <source>Mol Cancer Res</source>. <year>2010</year>;<volume>8</volume>(<issue>9</issue>):<fpage>1248</fpage>–<lpage>60</lpage>. doi: <pub-id pub-id-type="doi">10.1158/1541-7786.MCR-09-0473</pub-id>.</mixed-citation></ref>
<ref id="c11"><mixed-citation publication-type="journal"><string-name><surname>Chern</surname> <given-names>SR</given-names></string-name>, <string-name><surname>Li</surname> <given-names>SH</given-names></string-name>, <string-name><surname>Chiu</surname> <given-names>CL</given-names></string-name>, <string-name><surname>Chang</surname> <given-names>HH</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>CP</given-names></string-name>, <string-name><surname>Tsuen Chen</surname> <given-names>EI</given-names></string-name>. <article-title>Spatiotemporal expression of SERPINE2 in the human placenta and its role in extravillous trophoblast migration and invasion</article-title>. <source>Reprod Biol Endocrinol</source>. <year>2011</year>;<volume>9</volume>:<fpage>106</fpage>. doi:<pub-id pub-id-type="doi">10.1186/1477-7827-9-106</pub-id>.</mixed-citation></ref>
<ref id="c12"><mixed-citation publication-type="journal"><string-name><surname>Chien</surname> <given-names>J</given-names></string-name>, <string-name><surname>He</surname> <given-names>X</given-names></string-name>, <string-name><surname>Shridhar</surname> <given-names>V</given-names></string-name>. <article-title>Identification of tubulins as substrates of serine protease HtrA1 by mixture-based oriented peptide library screening</article-title>. <source>J Cell Biochem</source>. <year>2009a</year>;<volume>107</volume>(<issue>2</issue>):<fpage>253</fpage>–<lpage>263</lpage>. doi:<pub-id pub-id-type="doi">10.1002/jcb.22121</pub-id>.</mixed-citation></ref>
<ref id="c13"><mixed-citation publication-type="journal"><string-name><surname>Chien</surname> <given-names>J</given-names></string-name>, <string-name><surname>Ota</surname> <given-names>T</given-names></string-name>, <string-name><surname>Aletti</surname> <given-names>G</given-names></string-name>, <string-name><surname>Shridhar</surname> <given-names>R</given-names></string-name>, <string-name><surname>Boccellino</surname> <given-names>M</given-names></string-name>, <string-name><surname>Quagliuolo</surname> <given-names>L</given-names></string-name>, <string-name><surname>Baldi</surname> <given-names>A</given-names></string-name>, <string-name><surname>Shridhar</surname> <given-names>V</given-names></string-name>. <article-title>Serine protease HtrA1 associates with microtubules and inhibits cell migration</article-title>. <source>Mol Cell Biol</source>. <year>2009b</year>;<volume>29</volume>(<issue>15</issue>):<fpage>4177</fpage>–<lpage>87</lpage>. doi: <pub-id pub-id-type="doi">10.1128/MCB.00035-09</pub-id>.</mixed-citation></ref>
<ref id="c14"><mixed-citation publication-type="journal"><string-name><surname>Clawson</surname> <given-names>GA</given-names></string-name>, <string-name><surname>Bui</surname> <given-names>V</given-names></string-name>, <string-name><surname>Xin</surname> <given-names>P</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>N</given-names></string-name>, <string-name><surname>Pan</surname> <given-names>W</given-names></string-name>. <article-title>Intracellular localization of the tumor suppressor HtrA1/Prss11 and its association with HPV16 E6 and E7 proteins</article-title>. <source>J Cell Biochem</source>. <year>2008</year>;<volume>105</volume>(<issue>1</issue>):<fpage>81</fpage>–<lpage>88</lpage>. doi:<pub-id pub-id-type="doi">10.1002/jcb.21804</pub-id>.</mixed-citation></ref>
<ref id="c15"><mixed-citation publication-type="journal"><string-name><surname>Davidson</surname> <given-names>LA</given-names></string-name>, <string-name><surname>Keller</surname> <given-names>R</given-names></string-name>, <string-name><surname>DeSimone</surname> <given-names>DW</given-names></string-name>. <article-title>Assembly and remodeling of the fibrillar fibronectin extracellular matrix during gastrulation and neurulation in Xenopus laevis</article-title>. <source>Dev Dyn</source>. <year>2004</year>;<volume>231</volume>(<issue>4</issue>):<fpage>888</fpage>–<lpage>95</lpage>. doi: <pub-id pub-id-type="doi">10.1002/dvdy.20217</pub-id>.</mixed-citation></ref>
<ref id="c16"><mixed-citation publication-type="journal"><string-name><surname>Du Shane</surname> <given-names>GP</given-names></string-name>. <article-title>An experimental study of the origin of pigment cells in amphibia</article-title>. <source>J Exp Zool</source>. <year>1935</year>;<volume>72</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>31</lpage>.</mixed-citation></ref>
<ref id="c17"><mixed-citation publication-type="journal"><string-name><surname>Friedl</surname> <given-names>P</given-names></string-name>, <string-name><surname>Gilmour</surname> <given-names>D</given-names></string-name>. <article-title>Collective cell migration in morphogenesis, regeneration and cancer</article-title>. <source>Nat Rev Mol Cell Biol</source>. <year>2009</year>;<volume>10</volume>(<issue>7</issue>):<fpage>445</fpage>–<lpage>457</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrm2720</pub-id>.</mixed-citation></ref>
<ref id="c18"><mixed-citation publication-type="journal"><string-name><surname>Gouignard</surname> <given-names>N</given-names></string-name>, <string-name><surname>Maccarana</surname> <given-names>M</given-names></string-name>, <string-name><surname>Strate</surname> <given-names>I</given-names></string-name>, <string-name><surname>von Stedingk</surname> <given-names>K</given-names></string-name>, <string-name><surname>Malmström</surname> <given-names>A</given-names></string-name>, <string-name><surname>Pera</surname> <given-names>EM</given-names></string-name>. <article-title>Musculocontractural Ehlers-Danlos syndrome and neurocristopathies: dermatan sulfate is required for Xenopus neural crest cells to migrate and adhere to fibronectin</article-title>. <source>Dis Model Mech</source>. <year>2016</year>;<volume>9</volume>(<issue>6</issue>):<fpage>607</fpage>–<lpage>20</lpage>. doi: <pub-id pub-id-type="doi">10.1242/dmm.024661</pub-id>.</mixed-citation></ref>
<ref id="c19"><mixed-citation publication-type="journal"><string-name><surname>Gouignard</surname> <given-names>N</given-names></string-name>, <string-name><surname>Andrieu</surname> <given-names>C</given-names></string-name>, <string-name><surname>Theveneau</surname> <given-names>E</given-names></string-name>. <article-title>Neural crest delamination and migration: Looking forward to the next 150 years</article-title>. <source>Genesis</source>. <year>2018</year>;<volume>56</volume>(<issue>6-7</issue>):<fpage>e23107</fpage>. doi:<pub-id pub-id-type="doi">10.1002/dvg.23107</pub-id>.</mixed-citation></ref>
<ref id="c20"><mixed-citation publication-type="journal"><string-name><surname>Grau</surname> <given-names>S</given-names></string-name>, <string-name><surname>Richards</surname> <given-names>PJ</given-names></string-name>, <string-name><surname>Kerr</surname> <given-names>B</given-names></string-name>, <string-name><surname>Hughes</surname> <given-names>C</given-names></string-name>, <string-name><surname>Caterson</surname> <given-names>B</given-names></string-name>, <string-name><surname>Williams</surname> <given-names>AS</given-names></string-name>, <string-name><surname>Junker</surname> <given-names>U</given-names></string-name>, <string-name><surname>Jones</surname> <given-names>SA</given-names></string-name>, <string-name><surname>Clausen</surname> <given-names>T</given-names></string-name>, <string-name><surname>Ehrmann</surname> <given-names>M</given-names></string-name>. <article-title>The role of human HtrA1 in arthritic disease</article-title>. <source>J Biol Chem</source>. <year>2006</year>;<volume>281</volume>(<issue>10</issue>):<fpage>6124</fpage>–<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.M500361200</pub-id>.</mixed-citation></ref>
<ref id="c21"><mixed-citation publication-type="journal"><string-name><surname>Hadfield</surname> <given-names>KD</given-names></string-name>, <string-name><surname>Rock</surname> <given-names>CF</given-names></string-name>, <string-name><surname>Inkson</surname> <given-names>CA</given-names></string-name>, <string-name><surname>Dallas</surname> <given-names>SL</given-names></string-name>, <string-name><surname>Sudre</surname> <given-names>L</given-names></string-name>, <string-name><surname>Wallis</surname> <given-names>GA</given-names></string-name>, <string-name><surname>Boot-Handford</surname> <given-names>RP</given-names></string-name>, <string-name><surname>Canfield</surname> <given-names>AE</given-names></string-name>. <article-title>HtrA1 inhibits mineral deposition by osteoblasts: requirement for the protease and PDZ domains</article-title>. <source>J Biol Chem</source>. <year>2008</year>;<volume>283</volume>(<issue>9</issue>):<fpage>5928</fpage>–<lpage>38</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.M709299200</pub-id>.</mixed-citation></ref>
<ref id="c22"><mixed-citation publication-type="journal"><string-name><surname>Hanahan</surname> <given-names>D</given-names></string-name>, <string-name><surname>Weinberg</surname> <given-names>RA</given-names></string-name>. <article-title>Hallmarks of cancer: the next generation</article-title>. <source>Cell</source>. <year>2011</year>;<volume>144</volume>(<issue>5</issue>):<fpage>646</fpage>–<lpage>674</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2011.02.013</pub-id>.</mixed-citation></ref>
<ref id="c23"><mixed-citation publication-type="journal"><string-name><surname>Holstein</surname> <given-names>TW</given-names></string-name>. <article-title>The role of cnidarian developmental biology in unraveling axis formation and Wnt signaling</article-title>. <source>Dev Biol</source>. <year>2022</year>;<volume>487</volume>:<fpage>74</fpage>–<lpage>98</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ydbio.2022.04.005</pub-id>.</mixed-citation></ref>
<ref id="c24"><mixed-citation publication-type="journal"><string-name><surname>Hopwood</surname> <given-names>ND</given-names></string-name>, <string-name><surname>Pluck</surname> <given-names>A</given-names></string-name>, <string-name><surname>Gurdon</surname> <given-names>JB</given-names></string-name>. <article-title>A Xenopus mRNA related to Drosophila twist is expressed in response to induction in the mesoderm and the neural crest</article-title>. <source>Cell</source>. <year>1989</year>;<volume>59</volume>(<issue>5</issue>):<fpage>893</fpage>–<lpage>903</lpage>.</mixed-citation></ref>
<ref id="c25"><mixed-citation publication-type="journal"><string-name><surname>Hou</surname> <given-names>S</given-names></string-name>, <string-name><surname>Maccarana</surname> <given-names>M</given-names></string-name>, <string-name><surname>Min</surname> <given-names>TH</given-names></string-name>, <string-name><surname>Strate</surname> <given-names>I</given-names></string-name>, <string-name><surname>Pera</surname> <given-names>EM</given-names></string-name>. <article-title>The secreted serine protease xHtrA1 stimulates long-range FGF signaling in the early Xenopus embryo</article-title>. <source>Dev Cell</source>. <year>2007</year>;<volume>13</volume>(<issue>2</issue>):<fpage>226</fpage>–<lpage>241</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.devcel.2007.07.001</pub-id>.</mixed-citation></ref>
<ref id="c26"><mixed-citation publication-type="journal"><string-name><surname>Howie</surname> <given-names>RN</given-names></string-name>, <string-name><surname>Durham</surname> <given-names>EL</given-names></string-name>, <string-name><surname>Black</surname> <given-names>L</given-names></string-name>, <string-name><surname>Bennfors</surname> <given-names>G</given-names></string-name>, <string-name><surname>Parsons</surname> <given-names>TE</given-names></string-name>, <string-name><surname>Elsalanty</surname> <given-names>ME</given-names></string-name>, <string-name><surname>Yu</surname> <given-names>JC</given-names></string-name>, <string-name><surname>Weinberg</surname> <given-names>SM</given-names></string-name>, <string-name><given-names>Cray JJ</given-names> <surname>Jr</surname></string-name>. <article-title>Effects of In Utero Thyroxine Exposure on Murine Cranial Suture Growth</article-title>. <source>PLoS One</source>. <year>2016</year>;<volume>11</volume>(<issue>12</issue>):<fpage>e0167805</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0167805</pub-id>.</mixed-citation></ref>
<ref id="c27"><mixed-citation publication-type="journal"><string-name><surname>Jeyarajah</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Jaju Bhattad</surname> <given-names>G</given-names></string-name>, <string-name><surname>Kops</surname> <given-names>BF</given-names></string-name>, <string-name><surname>Renaud</surname> <given-names>SJ</given-names></string-name>. <article-title>Syndecan-4 regulates extravillous trophoblast migration by coordinating protein kinase C activation</article-title>. <source>Sci Rep</source>. <year>2019</year>;<volume>9</volume>(<issue>1</issue>):<fpage>10175</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41598-019-46599-6</pub-id>.</mixed-citation></ref>
<ref id="c28"><mixed-citation publication-type="journal"><string-name><surname>Keller-Pinter</surname> <given-names>A</given-names></string-name>, <string-name><surname>Gyulai-Nagy</surname> <given-names>S</given-names></string-name>, <string-name><surname>Becsky</surname> <given-names>D</given-names></string-name>, <string-name><surname>Dux</surname> <given-names>L</given-names></string-name>, <string-name><surname>Rovo</surname> <given-names>L</given-names></string-name>. <article-title>Syndecan-4 in Tumor Cell Motility</article-title>. <source>Cancers (Basel</source><italic>)</italic>. <year>2021</year>;<volume>13</volume>(<issue>13</issue>):<fpage>3322</fpage>. doi:<pub-id pub-id-type="doi">10.3390/cancers13133322</pub-id>.</mixed-citation></ref>
<ref id="c29"><mixed-citation publication-type="journal"><string-name><surname>Kim</surname> <given-names>GY</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>HY</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>HT</given-names></string-name>, <string-name><surname>Moon</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>CH</given-names></string-name>, <string-name><surname>Kang</surname> <given-names>S</given-names></string-name>, <string-name><surname>Rhim</surname> <given-names>H</given-names></string-name>. <article-title>HtrA1 is a novel antagonist controlling fibroblast growth factor (FGF) signaling via cleavage of FGF8</article-title>. <source>Mol Cell Biol</source>. <year>2012</year>;<volume>32</volume>(<issue>21</issue>):<fpage>4482</fpage>–<lpage>92</lpage>. doi: <pub-id pub-id-type="doi">10.1128/MCB.00872-12</pub-id>.</mixed-citation></ref>
<ref id="c30"><mixed-citation publication-type="journal"><string-name><surname>Kubota</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Ito</surname> <given-names>K</given-names></string-name>. <article-title>Chemotactic migration of mesencephalic neural crest cells in the mouse</article-title>. <source>Dev Dyn</source>. <year>2000</year>;<volume>217</volume>(<issue>2</issue>):<fpage>170</fpage>–<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1002/(SICI)1097-0177(200002)217:2</pub-id>&lt;170::AID-DVDY4&gt;3.0.CO;2-9.</mixed-citation></ref>
<ref id="c31"><mixed-citation publication-type="book"><string-name><surname>Le Douarin</surname> <given-names>N</given-names></string-name>, <string-name><surname>Kalcheim</surname> <given-names>C</given-names></string-name>. <chapter-title>The neural crest</chapter-title>. <edition>2nd edition</edition>. <person-group person-group-type="editor"><string-name><given-names>J.B.L.</given-names> <surname>Bard</surname></string-name>, <string-name><given-names>P.W.</given-names> <surname>Barlow</surname></string-name>, <string-name><given-names>D.L.</given-names> <surname>Kirk</surname></string-name></person-group> (Eds.) <source>Developmental and cell biology series</source>. <publisher-name>Cambridge University Press</publisher-name>, <publisher-loc>Cambridge</publisher-loc> (<year>1999</year>).</mixed-citation></ref>
<ref id="c32"><mixed-citation publication-type="journal"><string-name><surname>Lea</surname> <given-names>R</given-names></string-name>, <string-name><surname>Papalopulu</surname> <given-names>N</given-names></string-name>, <string-name><surname>Amaya</surname> <given-names>E</given-names></string-name>, <string-name><surname>Dorey</surname> <given-names>K</given-names></string-name>. <article-title>Temporal and spatial expression of FGF ligands and receptors during Xenopus development</article-title>. <source>Dev Dyn</source>. <year>2009</year>;<volume>238</volume>(<issue>6</issue>):<fpage>1467</fpage>–<lpage>79</lpage>. doi: <pub-id pub-id-type="doi">10.1002/dvdy.21913</pub-id>.</mixed-citation></ref>
<ref id="c33"><mixed-citation publication-type="journal"><string-name><surname>Leblanc</surname> <given-names>R</given-names></string-name>, <string-name><surname>Sahay</surname> <given-names>D</given-names></string-name>, <string-name><surname>Houssin</surname> <given-names>A</given-names></string-name>, <string-name><surname>Machuca-Gayet</surname> <given-names>I</given-names></string-name>, <string-name><surname>Peyruchaud</surname> <given-names>O</given-names></string-name>. <article-title>Autotaxin-β interaction with the cell surface via syndecan-4 impacts on cancer cell proliferation and metastasis</article-title>. <source>Oncotarget</source>. <year>2018</year>;<volume>9</volume>(<issue>69</issue>):<fpage>33170</fpage>–<lpage>33185</lpage>. doi:<pub-id pub-id-type="doi">10.18632/oncotarget.26039</pub-id>.</mixed-citation></ref>
<ref id="c34"><mixed-citation publication-type="journal"><string-name><surname>Lee</surname> <given-names>HX</given-names></string-name>, <string-name><surname>Ambrosio</surname> <given-names>AL</given-names></string-name>, <string-name><surname>Reversade</surname> <given-names>B</given-names></string-name>, <string-name><surname>De Robertis</surname> <given-names>EM</given-names></string-name>. <article-title>Embryonic dorsal-ventral signaling: secreted frizzled-related proteins as inhibitors of tolloid proteinases</article-title>. <source>Cell</source>. <year>2006</year>;<volume>124</volume>(<issue>1</issue>):<fpage>147</fpage>–<lpage>59</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2005.12.018</pub-id>.</mixed-citation></ref>
<ref id="c35"><mixed-citation publication-type="journal"><string-name><surname>Li</surname> <given-names>W</given-names></string-name>, <string-name><surname>Huntington</surname> <given-names>JA</given-names></string-name>. <article-title>Crystal structures of protease nexin-1 in complex with heparin and thrombin suggest a 2-step recognition mechanism</article-title>. <source>Blood</source>. <year>2012</year>;<volume>120</volume>(<issue>2</issue>):<fpage>459</fpage>–<lpage>467</lpage>. doi:<pub-id pub-id-type="doi">10.1182/blood-2012-03-415869</pub-id>.</mixed-citation></ref>
<ref id="c36"><mixed-citation publication-type="journal"><string-name><surname>Manon-Jensen</surname> <given-names>T</given-names></string-name>, <string-name><surname>Multhaupt</surname> <given-names>HA</given-names></string-name>, <string-name><surname>Couchman</surname> <given-names>JR</given-names></string-name>. <article-title>Mapping of matrix metalloproteinase cleavage sites on syndecan-1 and syndecan-4 ectodomains</article-title>. <source>FEBS J</source>. <year>2013</year>;<volume>280</volume>(<issue>10</issue>):<fpage>2320</fpage>–<lpage>2331</lpage>. doi:<pub-id pub-id-type="doi">10.1111/febs.12174</pub-id>.</mixed-citation></ref>
<ref id="c37"><mixed-citation publication-type="journal"><string-name><surname>Matsuo</surname> <given-names>I</given-names></string-name>, <string-name><surname>Kimura-Yoshida</surname> <given-names>C</given-names></string-name>. <article-title>Extracellular modulation of Fibroblast Growth Factor signaling through heparan sulfate proteoglycans in mammalian development</article-title>. <source>Curr Opin Genet Dev</source>. <year>2013</year>;<volume>23</volume>(<issue>4</issue>):<fpage>399</fpage>–<lpage>407</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.gde.2013.02.004</pub-id>.</mixed-citation></ref>
<ref id="c38"><mixed-citation publication-type="journal"><string-name><surname>Matthews</surname> <given-names>HK</given-names></string-name>, <string-name><surname>Marchant</surname> <given-names>L</given-names></string-name>, <string-name><surname>Carmona-Fontaine</surname> <given-names>C</given-names></string-name>, <string-name><surname>Kuriyama</surname> <given-names>S</given-names></string-name>, <string-name><surname>Larraín</surname> <given-names>J</given-names></string-name>, <string-name><surname>Holt</surname> <given-names>MR</given-names></string-name>, <string-name><surname>Parsons</surname> <given-names>M</given-names></string-name>, <string-name><surname>Mayor</surname> <given-names>R</given-names></string-name>. <article-title>Directional migration of neural crest cells in vivo is regulated by Syndecan-4/Rac1 and non-canonical Wnt signaling/RhoA</article-title>. <source>Development</source>. <year>2008</year>;<volume>135</volume>(<issue>10</issue>):<fpage>1771</fpage>–<lpage>80</lpage>. doi: <pub-id pub-id-type="doi">10.1242/dev.017350</pub-id>.</mixed-citation></ref>
<ref id="c39"><mixed-citation publication-type="journal"><string-name><surname>Medina-Cuadra</surname> <given-names>L</given-names></string-name>, <string-name><surname>Monsoro-Burq</surname> <given-names>AH</given-names></string-name>. <article-title>Xenopus, an emerging model for studying pathologies of the neural crest</article-title>. <source>Curr Top Dev Biol</source>. <year>2021</year>;<volume>145</volume>:<fpage>313</fpage>–<lpage>348</lpage>. doi: <pub-id pub-id-type="doi">10.1016/bs.ctdb.2021.03.002</pub-id>.</mixed-citation></ref>
<ref id="c40"><mixed-citation publication-type="journal"><string-name><surname>Menoud</surname> <given-names>PA</given-names></string-name>, <string-name><surname>Debrot</surname> <given-names>S</given-names></string-name>, <string-name><surname>Schowing</surname> <given-names>J</given-names></string-name>. <article-title>Mouse neural crest cells secrete both urokinase-type and tissue-type plasminogen activators in vitro</article-title>. <source>Development</source>. <year>1989</year>;<volume>106</volume>(<issue>4</issue>):<fpage>685</fpage>–<lpage>690</lpage>. doi:<pub-id pub-id-type="doi">10.1242/dev.106.4.685</pub-id>.</mixed-citation></ref>
<ref id="c41"><mixed-citation publication-type="journal"><string-name><surname>Minoux</surname> <given-names>M</given-names></string-name>, <string-name><surname>Rijli</surname> <given-names>FM</given-names></string-name>. <article-title>Molecular mechanisms of cranial neural crest cell migration and patterning in craniofacial development</article-title>. <source>Development</source>. <year>2010</year>;<volume>137</volume>(<issue>16</issue>):<fpage>2605</fpage>–<lpage>2621</lpage>. doi:<pub-id pub-id-type="doi">10.1242/dev.040048</pub-id>.</mixed-citation></ref>
<ref id="c42"><mixed-citation publication-type="journal"><string-name><surname>Monard</surname> <given-names>D</given-names></string-name>. <article-title>SERPINE2/Protease Nexin-1 in vivo multiple functions: Does the puzzle make sense?</article-title>. <source>Semin Cell Dev Biol</source>. <year>2017</year>;<volume>62</volume>:<fpage>160</fpage>–<lpage>169</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.semcdb.2016.08.012</pub-id>.</mixed-citation></ref>
<ref id="c43"><mixed-citation publication-type="journal"><string-name><surname>Nieto</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Huang</surname> <given-names>RY</given-names></string-name>, <string-name><surname>Jackson</surname> <given-names>RA</given-names></string-name>, <string-name><surname>Thiery</surname> <given-names>JP.</given-names></string-name> <article-title>EMT: 2016</article-title>. <source>Cell</source>. <year>2016</year>;<volume>166</volume>(<issue>1</issue>):<fpage>21</fpage>–<lpage>45</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2016.06.028</pub-id>.</mixed-citation></ref>
<ref id="c44"><mixed-citation publication-type="journal"><string-name><surname>O’Connell</surname> <given-names>MP</given-names></string-name>, <string-name><surname>Fiori</surname> <given-names>JL</given-names></string-name>, <string-name><surname>Kershner</surname> <given-names>EK</given-names></string-name>, <string-name><surname>Frank</surname> <given-names>BP</given-names></string-name>, <string-name><surname>Indig</surname> <given-names>FE</given-names></string-name>, <string-name><surname>Taub</surname> <given-names>DD</given-names></string-name>, <string-name><surname>Hoek</surname> <given-names>KS</given-names></string-name>, <string-name><surname>Weeraratna</surname> <given-names>AT</given-names></string-name>. <article-title>Heparan sulfate proteoglycan modulation of Wnt5A signal transduction in metastatic melanoma cells</article-title>. <source>J Biol Chem</source>. <year>2009</year>;<volume>284</volume>(<issue>42</issue>):<fpage>28704</fpage>–<lpage>12</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.M109.028498</pub-id>.</mixed-citation></ref>
<ref id="c45"><mixed-citation publication-type="journal"><string-name><surname>Olson</surname> <given-names>ST</given-names></string-name>, <string-name><surname>Gettins</surname> <given-names>PG</given-names></string-name>. <article-title>Regulation of proteases by protein inhibitors of the serpin superfamily</article-title>. <source>Prog Mol Biol Transl Sci</source>. <year>2011</year>;<volume>99</volume>:<fpage>185</fpage>–<lpage>240</lpage>. doi:<pub-id pub-id-type="doi">10.1016/B978-0-12-385504-6.00005-1</pub-id>.</mixed-citation></ref>
<ref id="c46"><mixed-citation publication-type="journal"><string-name><surname>Onuma</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Asashima</surname> <given-names>M</given-names></string-name>, <string-name><surname>Whitman</surname> <given-names>M</given-names></string-name>. <article-title>A Serpin family gene, protease nexin-1 has an activity distinct from protease inhibition in early Xenopus embryos</article-title>. <source>Mech Dev</source>. <year>2006</year>;<volume>123</volume>(<issue>6</issue>):<fpage>463</fpage>–<lpage>471</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.mod.2006.04.005</pub-id>.</mixed-citation></ref>
<ref id="c47"><mixed-citation publication-type="journal"><string-name><surname>Owji</surname> <given-names>H</given-names></string-name>, <string-name><surname>Nezafat</surname> <given-names>N</given-names></string-name>, <string-name><surname>Negahdaripour</surname> <given-names>M</given-names></string-name>, <string-name><surname>Hajiebrahimi</surname> <given-names>A</given-names></string-name>, <string-name><surname>Ghasemi</surname> <given-names>Y</given-names></string-name>. <article-title>A comprehensive review of signal peptides: Structure, roles, and applications</article-title>. <source>Eur J Cell Biol</source>. <year>2018</year>;<volume>97</volume>(<issue>6</issue>):<fpage>422</fpage>–<lpage>441</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ejcb.2018.06.003</pub-id>.</mixed-citation></ref>
<ref id="c48"><mixed-citation publication-type="journal"><string-name><surname>Pei</surname> <given-names>X</given-names></string-name>, <string-name><surname>Ma</surname> <given-names>K</given-names></string-name>, <string-name><surname>Xu</surname> <given-names>J</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>N</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>N</given-names></string-name>. <article-title>Inhibition of cell proliferation and migration after HTRA1 knockdown in retinal pigment epithelial cells</article-title>. <source>Graefes Arch Clin Exp Ophthalmol</source>. <year>2015</year>;<volume>253</volume>(<issue>4</issue>):<fpage>565</fpage>–<lpage>572</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00417-014-2901-2</pub-id>.</mixed-citation></ref>
<ref id="c49"><mixed-citation publication-type="journal"><string-name><surname>Pera</surname> <given-names>EM</given-names></string-name>, <string-name><surname>Hou</surname> <given-names>S</given-names></string-name>, <string-name><surname>Strate</surname> <given-names>I</given-names></string-name>, <string-name><surname>Wessely</surname> <given-names>O</given-names></string-name>, <string-name><surname>De Robertis</surname> <given-names>EM</given-names></string-name>. <article-title>Exploration of the extracellular space by a large-scale secretion screen in the early Xenopus embryo</article-title>. <source>Int J Dev Biol</source>. <year>2005</year>;<volume>49</volume>(<issue>7</issue>):<fpage>781</fpage>–<lpage>796</lpage>. doi:<pub-id pub-id-type="doi">10.1387/ijdb.052003ep</pub-id>.</mixed-citation></ref>
<ref id="c50"><mixed-citation publication-type="book"><string-name><surname>Pera</surname> <given-names>EM</given-names></string-name>, <string-name><surname>Acosta</surname> <given-names>H</given-names></string-name>, <string-name><surname>Gouignard</surname> <given-names>N</given-names></string-name>, <string-name><surname>Climent</surname> <given-names>M.</given-names></string-name> <chapter-title>Whole-Mount In Situ Hybridization and Immunohistochemistry in <italic>Xenopus</italic> Embryos</chapter-title>. In: <person-group person-group-type="editor"><string-name><given-names>G.</given-names> <surname>Hauptmann</surname></string-name></person-group> (Ed.) <source>In Situ Hybridization Methods. Neuromethods</source>, vol <volume>99</volume>. <publisher-name>Humana Press</publisher-name>, <publisher-loc>New York, NY</publisher-loc>. (<year>2015</year>). <pub-id pub-id-type="doi">10.1007/978-1-4939-2303-8_8</pub-id>.</mixed-citation></ref>
<ref id="c51"><mixed-citation publication-type="journal"><string-name><surname>Piacentino</surname> <given-names>ML</given-names></string-name>, <string-name><surname>Li</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Bronner</surname> <given-names>ME</given-names></string-name>. <article-title>Epithelial-to-mesenchymal transition and different migration strategies as viewed from the neural crest</article-title>. <source>Curr Opin Cell Biol</source>. <year>2020</year>;<volume>66</volume>:<fpage>43</fpage>–<lpage>50</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ceb.2020.05.001</pub-id>.</mixed-citation></ref>
<ref id="c52"><mixed-citation publication-type="journal"><string-name><surname>Piccolo</surname> <given-names>S</given-names></string-name>, <string-name><surname>Agius</surname> <given-names>E</given-names></string-name>, <string-name><surname>Lu</surname> <given-names>B</given-names></string-name>, <string-name><surname>Goodman</surname> <given-names>S</given-names></string-name>, <string-name><surname>Dale</surname> <given-names>L</given-names></string-name>, <string-name><surname>De Robertis</surname> <given-names>EM</given-names></string-name>. <article-title>Cleavage of Chordin by Xolloid metalloprotease suggests a role for proteolytic processing in the regulation of Spemann organizer activity</article-title>. <source>Cell</source>. <year>1997</year>;<volume>91</volume>(<issue>3</issue>):<fpage>407</fpage>–<lpage>16</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s0092-8674(00)80424-9</pub-id>.</mixed-citation></ref>
<ref id="c53"><mixed-citation publication-type="journal"><string-name><surname>Rooryck</surname> <given-names>C</given-names></string-name>, <string-name><surname>Diaz-Font</surname> <given-names>A</given-names></string-name>, <string-name><surname>Osborn</surname> <given-names>DP</given-names></string-name>, <string-name><surname>Chabchoub</surname> <given-names>E</given-names></string-name>, <string-name><surname>Hernandez-Hernandez</surname> <given-names>V</given-names></string-name>, <string-name><surname>Shamseldin</surname> <given-names>H</given-names></string-name>, <string-name><surname>Kenny</surname> <given-names>J</given-names></string-name>, <string-name><surname>Waters</surname> <given-names>A</given-names></string-name>, <string-name><surname>Jenkins</surname> <given-names>D</given-names></string-name>, <string-name><surname>Kaissi</surname> <given-names>AA</given-names></string-name>, <string-name><surname>Leal</surname> <given-names>GF</given-names></string-name>, <string-name><surname>Dallapiccola</surname> <given-names>B</given-names></string-name>, <string-name><surname>Carnevale</surname> <given-names>F</given-names></string-name>, <string-name><surname>Bitner-Glindzicz</surname> <given-names>M</given-names></string-name>, <string-name><surname>Lees</surname> <given-names>M</given-names></string-name>, <string-name><surname>Hennekam</surname> <given-names>R</given-names></string-name>, <string-name><surname>Stanier</surname> <given-names>P</given-names></string-name>, <string-name><surname>Burns</surname> <given-names>AJ</given-names></string-name>, <string-name><surname>Peeters</surname> <given-names>H</given-names></string-name>, <string-name><surname>Alkuraya</surname> <given-names>FS</given-names></string-name>, <string-name><surname>Beales</surname> <given-names>PL</given-names></string-name>. <article-title>Mutations in lectin complement pathway genes COLEC11 and MASP1 cause 3MC syndrome</article-title>. <source>Nat Genet</source>. <year>2011</year>;<volume>43</volume>(<issue>3</issue>):<fpage>197</fpage>–<lpage>203</lpage>. doi: <pub-id pub-id-type="doi">10.1038/ng.757</pub-id>.</mixed-citation></ref>
<ref id="c54"><mixed-citation publication-type="journal"><string-name><surname>Sadaghiani</surname> <given-names>B</given-names></string-name>, <string-name><surname>Thiébaud</surname> <given-names>CH</given-names></string-name>. <article-title>Neural crest development in the Xenopus laevis embryo, studied by interspecific transplantation and scanning electron microscopy</article-title>. <source>Dev Biol</source>. <year>1987</year>;<volume>124</volume>(<issue>1</issue>):<fpage>91</fpage>–<lpage>110</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0012-1606(87)90463-5</pub-id>.</mixed-citation></ref>
<ref id="c55"><mixed-citation publication-type="journal"><string-name><surname>Saksela</surname> <given-names>O</given-names></string-name>, <string-name><surname>Moscatelli</surname> <given-names>D</given-names></string-name>, <string-name><surname>Sommer</surname> <given-names>A</given-names></string-name>, <string-name><surname>Rifkin</surname> <given-names>DB</given-names></string-name>. <article-title>Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation</article-title>. <source>J Cell Biol</source>. <year>1988</year>;<volume>107</volume>(<issue>2</issue>):<fpage>743</fpage>–<lpage>51</lpage>. doi: <pub-id pub-id-type="doi">10.1083/jcb.107.2.743</pub-id>.</mixed-citation></ref>
<ref id="c56"><mixed-citation publication-type="journal"><string-name><surname>Sato</surname> <given-names>A</given-names></string-name>, <string-name><surname>Scholl</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Kuhn</surname> <given-names>EN</given-names></string-name>, <string-name><surname>Stadt</surname> <given-names>HA</given-names></string-name>, <string-name><surname>Decker</surname> <given-names>JR</given-names></string-name>, <string-name><surname>Pegram</surname> <given-names>K</given-names></string-name>, <string-name><surname>Hutson</surname> <given-names>MR</given-names></string-name>, <string-name><surname>Kirby</surname> <given-names>ML</given-names></string-name>. <article-title>FGF8 signaling is chemotactic for cardiac neural crest cells</article-title>. <source>Dev Biol</source>. <year>2011</year>;<volume>354</volume>(<issue>1</issue>):<fpage>18</fpage>–<lpage>30</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ydbio.2011.03.010</pub-id>.</mixed-citation></ref>
<ref id="c57"><mixed-citation publication-type="journal"><string-name><surname>Schock</surname> <given-names>EN</given-names></string-name>, <string-name><surname>York</surname> <given-names>JR</given-names></string-name>, <string-name><surname>LaBonne</surname> <given-names>C</given-names></string-name>. <article-title>The developmental and evolutionary origins of cellular pluripotency in the vertebrate neural crest</article-title>. <source>Semin Cell Dev Biol</source>. <year>2023</year>;<volume>138</volume>:<fpage>36</fpage>–<lpage>44</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.semcdb.2022.04.008</pub-id>.</mixed-citation></ref>
<ref id="c58"><mixed-citation publication-type="journal"><string-name><surname>Seetharaman</surname> <given-names>S</given-names></string-name>, <string-name><surname>Etienne-Manneville</surname> <given-names>S</given-names></string-name>. <article-title>Cytoskeletal Crosstalk in Cell Migration</article-title>. <source>Trends Cell Biol</source>. <year>2020</year>;<volume>30</volume>(<issue>9</issue>):<fpage>720</fpage>–<lpage>735</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.tcb.2020.06.004</pub-id></mixed-citation></ref>
<ref id="c59"><mixed-citation publication-type="journal"><string-name><surname>Session</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Uno</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Kwon</surname> <given-names>T</given-names></string-name>, <string-name><surname>Chapman</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Toyoda</surname> <given-names>A</given-names></string-name>, <string-name><surname>Takahashi</surname> <given-names>S</given-names></string-name>, <string-name><surname>Fukui</surname> <given-names>A</given-names></string-name>, <string-name><surname>Hikosaka</surname> <given-names>A</given-names></string-name>, <string-name><surname>Suzuki</surname> <given-names>A</given-names></string-name>, <string-name><surname>Kondo</surname> <given-names>M</given-names></string-name>, <string-name><surname>van Heeringen</surname> <given-names>SJ</given-names></string-name>, <string-name><surname>Quigley</surname> <given-names>I</given-names></string-name>, <string-name><surname>Heinz</surname> <given-names>S</given-names></string-name>, <string-name><surname>Ogino</surname> <given-names>H</given-names></string-name>, <string-name><surname>Ochi</surname> <given-names>H</given-names></string-name>, <string-name><surname>Hellsten</surname> <given-names>U</given-names></string-name>, <string-name><surname>Lyons</surname> <given-names>JB</given-names></string-name>, <string-name><surname>Simakov</surname> <given-names>O</given-names></string-name>, <string-name><surname>Putnam</surname> <given-names>N</given-names></string-name>, <string-name><surname>Stites</surname> <given-names>J</given-names></string-name>, <string-name><surname>Kuroki</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Tanaka</surname> <given-names>T</given-names></string-name>, <string-name><surname>Michiue</surname> <given-names>T</given-names></string-name>, <string-name><surname>Watanabe</surname> <given-names>M</given-names></string-name>, <string-name><surname>Bogdanovic</surname> <given-names>O</given-names></string-name>, <string-name><surname>Lister</surname> <given-names>R</given-names></string-name>, <string-name><surname>Georgiou</surname> <given-names>G</given-names></string-name>, <string-name><surname>Paranjpe</surname> <given-names>SS</given-names></string-name>, <string-name><surname>van Kruijsbergen</surname> <given-names>I</given-names></string-name>, <string-name><surname>Shu</surname> <given-names>S</given-names></string-name>, <string-name><surname>Carlson</surname> <given-names>J</given-names></string-name>, <string-name><surname>Kinoshita</surname> <given-names>T</given-names></string-name>, <string-name><surname>Ohta</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Mawaribuchi</surname> <given-names>S</given-names></string-name>, <string-name><surname>Jenkins</surname> <given-names>J</given-names></string-name>, <string-name><surname>Grimwood</surname> <given-names>J</given-names></string-name>, <string-name><surname>Schmutz</surname> <given-names>J</given-names></string-name>, <string-name><surname>Mitros</surname> <given-names>T</given-names></string-name>, <string-name><surname>Mozaffari</surname> <given-names>SV</given-names></string-name>, <string-name><surname>Suzuki</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Haramoto</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Yamamoto</surname> <given-names>TS</given-names></string-name>, <string-name><surname>Takagi</surname> <given-names>C</given-names></string-name>, <string-name><surname>Heald</surname> <given-names>R</given-names></string-name>, <string-name><surname>Miller</surname> <given-names>K</given-names></string-name>, <string-name><surname>Haudenschild</surname> <given-names>C</given-names></string-name>, <string-name><surname>Kitzman</surname> <given-names>J</given-names></string-name>, <string-name><surname>Nakayama</surname> <given-names>T</given-names></string-name>, <string-name><surname>Izutsu</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Robert</surname> <given-names>J</given-names></string-name>, <string-name><surname>Fortriede</surname> <given-names>J</given-names></string-name>, <string-name><surname>Burns</surname> <given-names>K</given-names></string-name>, <string-name><surname>Lotay</surname> <given-names>V</given-names></string-name>, <string-name><surname>Karimi</surname> <given-names>K</given-names></string-name>, <string-name><surname>Yasuoka</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Dichmann</surname> <given-names>DS</given-names></string-name>, <string-name><surname>Flajnik</surname> <given-names>MF</given-names></string-name>, <string-name><surname>Houston</surname> <given-names>DW</given-names></string-name>, <string-name><surname>Shendure</surname> <given-names>J</given-names></string-name>, <string-name><surname>DuPasquier</surname> <given-names>L</given-names></string-name>, <string-name><surname>Vize</surname> <given-names>PD</given-names></string-name>, <string-name><surname>Zorn</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Ito</surname> <given-names>M</given-names></string-name>, <string-name><surname>Marcotte</surname> <given-names>EM</given-names></string-name>, <string-name><surname>Wallingford</surname> <given-names>JB</given-names></string-name>, <string-name><surname>Ito</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Asashima</surname> <given-names>M</given-names></string-name>, <string-name><surname>Ueno</surname> <given-names>N</given-names></string-name>, <string-name><surname>Matsuda</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Veenstra</surname> <given-names>GJ</given-names></string-name>, <string-name><surname>Fujiyama</surname> <given-names>A</given-names></string-name>, <string-name><surname>Harland</surname> <given-names>RM</given-names></string-name>, <string-name><surname>Taira</surname> <given-names>M</given-names></string-name>, <string-name><surname>Rokhsar</surname> <given-names>DS</given-names></string-name>. <article-title>Genome evolution in the allotetraploid frog Xenopus laevis</article-title>. <source>Nature</source>. <year>2016</year>;<volume>538</volume>(7625):<fpage>336</fpage>–<lpage>343</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nature19840</pub-id>.</mixed-citation></ref>
<ref id="c60"><mixed-citation publication-type="journal"><string-name><surname>Shellard</surname> <given-names>A</given-names></string-name>, <string-name><surname>Mayor</surname> <given-names>R</given-names></string-name>. <article-title>Rules of collective migration: from the wildebeest to the neural crest</article-title>. <source>Philos Trans R Soc Lond B Biol Sci</source>. <year>2020</year>;<volume>375</volume>(<issue>1807</issue>):<fpage>20190387</fpage>. doi:<pub-id pub-id-type="doi">10.1098/rstb.2019.0387</pub-id>.</mixed-citation></ref>
<ref id="c61"><mixed-citation publication-type="journal"><string-name><surname>Sommer</surname> <given-names>A</given-names></string-name>, <string-name><surname>Rifkin</surname> <given-names>DB</given-names></string-name>. <article-title>Interaction of heparin with human basic fibroblast growth factor: protection of the angiogenic protein from proteolytic degradation by a glycosaminoglycan</article-title>. <source>J Cell Physiol</source>. <year>1989</year>;<volume>138</volume>(<issue>1</issue>):<fpage>215</fpage>–<lpage>20</lpage>. doi: <pub-id pub-id-type="doi">10.1002/jcp.1041380129</pub-id>.</mixed-citation></ref>
<ref id="c62"><mixed-citation publication-type="journal"><string-name><surname>Stone</surname> <given-names>LS</given-names></string-name>. <article-title>Experiments on the development of the cranial ganglia and the lateral line sense organs in Amblystoma</article-title>. <source>J Exp Zool</source>. <year>1922</year>;<volume>35</volume>:<fpage>421</fpage>–<lpage>495</lpage>.</mixed-citation></ref>
<ref id="c63"><mixed-citation publication-type="journal"><string-name><surname>Stone</surname> <given-names>LS</given-names></string-name>. <article-title>Further experiments on the extirpation and transplantation of mesectoderm in Amblystoma punctatum</article-title>. <source>J Exp Zool</source>. <year>1926</year>;<volume>44</volume>:<fpage>95</fpage>–<lpage>131</lpage>.</mixed-citation></ref>
<ref id="c64"><mixed-citation publication-type="journal"><string-name><surname>Suzuki</surname> <given-names>T</given-names></string-name>, <string-name><surname>Kusakabe</surname> <given-names>M</given-names></string-name>, <string-name><surname>Nakayama</surname> <given-names>K</given-names></string-name>, <string-name><surname>Nishida</surname> <given-names>E</given-names></string-name>. <article-title>The protein kinase MLTK regulates chondrogenesis by inducing the transcription factor Sox6</article-title>. <source>Development</source>. <year>2012</year>;<volume>139</volume>(<issue>16</issue>):<fpage>2988</fpage>–<lpage>98</lpage>. doi: <pub-id pub-id-type="doi">10.1242/dev.078675</pub-id>.</mixed-citation></ref>
<ref id="c65"><mixed-citation publication-type="journal"><string-name><surname>Szabó</surname> <given-names>A</given-names></string-name>, <string-name><surname>Mayor</surname> <given-names>R</given-names></string-name>. <article-title>Mechanisms of Neural Crest Migration</article-title>. <source>Annu Rev Genet</source>. <year>2018</year>;<volume>52</volume>:<fpage>43</fpage>–<lpage>63</lpage>. doi: <pub-id pub-id-type="doi">10.1146/annurev-genet-120417-031559</pub-id>.</mixed-citation></ref>
<ref id="c66"><mixed-citation publication-type="journal"><string-name><surname>Tang</surname> <given-names>T</given-names></string-name>, <string-name><surname>Zhu</surname> <given-names>Q</given-names></string-name>, <string-name><surname>Li</surname> <given-names>X</given-names></string-name>, <string-name><surname>Zhu</surname> <given-names>G</given-names></string-name>, <string-name><surname>Deng</surname> <given-names>S</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Ni</surname> <given-names>L</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>X</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Xia</surname> <given-names>T</given-names></string-name>, <string-name><surname>Zen</surname> <given-names>K</given-names></string-name>, <string-name><surname>Pan</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Jin</surname> <given-names>L</given-names></string-name>. <article-title>Protease Nexin I is a feedback regulator of EGF/PKC/MAPK/EGR1 signaling in breast cancer cells metastasis and stemness</article-title>. <source>Cell Death Dis</source>. <year>2019</year>;<volume>10</volume>(<issue>9</issue>):<fpage>649</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41419-019-1882-9</pub-id>. Erratum in: Cell Death Dis. 2020;11(1):13.</mixed-citation></ref>
<ref id="c67"><mixed-citation publication-type="journal"><string-name><surname>Tucker</surname> <given-names>RP</given-names></string-name>. <article-title>The role of glycosaminoglycans in anuran pigment cell migration</article-title>. <source>J Embryol Exp Morphol</source>. <year>1986</year>;<volume>92</volume>:<fpage>145</fpage>–<lpage>164</lpage></mixed-citation></ref>
<ref id="c68"><mixed-citation publication-type="journal"><string-name><surname>Tucker</surname> <given-names>AS</given-names></string-name>, <string-name><surname>Slack</surname> <given-names>JM</given-names></string-name>. <article-title>Independent induction and formation of the dorsal and ventral fins in Xenopus laevis</article-title>. <source>Dev Dyn</source>. <year>2004</year>;<volume>230</volume>(<issue>3</issue>):<fpage>461</fpage>–<lpage>467</lpage>. doi:<pub-id pub-id-type="doi">10.1002/dvdy.20071</pub-id></mixed-citation></ref>
<ref id="c69"><mixed-citation publication-type="journal"><string-name><surname>Valinsky</surname> <given-names>JE</given-names></string-name>, <string-name><surname>Le Douarin</surname> <given-names>NM</given-names></string-name>. <article-title>Production of plasminogen activator by migrating cephalic neural crest cells</article-title>. <source>EMBO J</source>. <year>1985</year>;<volume>4</volume>(<issue>6</issue>):<fpage>1403</fpage>–<lpage>1406</lpage>. doi:<pub-id pub-id-type="doi">10.1002/j.1460-2075.1985.tb03793.x</pub-id></mixed-citation></ref>
<ref id="c70"><mixed-citation publication-type="journal"><string-name><surname>Wagenblast</surname> <given-names>E</given-names></string-name>, <string-name><surname>Soto</surname> <given-names>M</given-names></string-name>, <string-name><surname>Gutiérrez-Ángel</surname> <given-names>S</given-names></string-name>, <string-name><surname>Hartl</surname> <given-names>CA</given-names></string-name>, <string-name><surname>Gable</surname> <given-names>AL</given-names></string-name>, <string-name><surname>Maceli</surname> <given-names>AR</given-names></string-name>, <string-name><surname>Erard</surname> <given-names>N</given-names></string-name>, <string-name><surname>Williams</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>SY</given-names></string-name>, <string-name><surname>Dickopf</surname> <given-names>S</given-names></string-name>, <string-name><surname>Harrell</surname> <given-names>JC</given-names></string-name>, <string-name><surname>Smith</surname> <given-names>AD</given-names></string-name>, <string-name><surname>Perou</surname> <given-names>CM</given-names></string-name>, <string-name><surname>Wilkinson</surname> <given-names>JE</given-names></string-name>, <string-name><surname>Hannon</surname> <given-names>GJ</given-names></string-name>, <string-name><surname>Knott</surname> <given-names>SR</given-names></string-name>. <article-title>A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis</article-title>. <source>Nature</source>. <year>2015</year>;<volume>520</volume>(7547):<fpage>358</fpage>–<lpage>62</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nature14403</pub-id>.</mixed-citation></ref>
<ref id="c71"><mixed-citation publication-type="journal"><string-name><surname>Wang</surname> <given-names>N</given-names></string-name>, <string-name><surname>Eckert</surname> <given-names>KA</given-names></string-name>, <string-name><surname>Zomorrodi</surname> <given-names>AR</given-names></string-name>, <string-name><surname>Xin</surname> <given-names>P</given-names></string-name>, <string-name><surname>Pan</surname> <given-names>W</given-names></string-name>, <string-name><surname>Shearer</surname> <given-names>DA</given-names></string-name>, <string-name><surname>Weisz</surname> <given-names>J</given-names></string-name>, <string-name><surname>Maranus</surname> <given-names>CD</given-names></string-name>, <string-name><surname>Clawson</surname> <given-names>GA</given-names></string-name>. <article-title>Down-regulation of HtrA1 activates the epithelial-mesenchymal transition and ATM DNA damage response pathways</article-title>. <source>PLoS One</source>. <year>2012</year>;<volume>7</volume>(<issue>6</issue>):<fpage>e39446</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0039446</pub-id>.</mixed-citation></ref>
<ref id="c72"><mixed-citation publication-type="journal"><string-name><surname>Woods</surname> <given-names>A</given-names></string-name>, <string-name><surname>Couchman</surname> <given-names>JR</given-names></string-name>. <article-title>Syndecan-4 and focal adhesion function</article-title>. <source>Curr Opin Cell Biol</source>. <year>2001</year>;<volume>13</volume>(<issue>5</issue>):<fpage>578</fpage>–<lpage>583</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s0955-0674(00)00254-4</pub-id>.</mixed-citation></ref>
<ref id="c73"><mixed-citation publication-type="journal"><string-name><surname>Wu</surname> <given-names>QW</given-names></string-name>. <article-title>Serpine2, a potential novel target for combating melanoma metastasis</article-title>. <source>Am J Transl Res</source>. <year>2016</year>;<volume>8</volume>(<issue>5</issue>):<fpage>1985</fpage>–<lpage>1997</lpage>.</mixed-citation></ref>
<ref id="c74"><mixed-citation publication-type="journal"><string-name><surname>Ziegler</surname> <given-names>B</given-names></string-name>, <string-name><surname>Yiallouros</surname> <given-names>I</given-names></string-name>, <string-name><surname>Trageser</surname> <given-names>B</given-names></string-name>, <string-name><surname>Kumar</surname> <given-names>S</given-names></string-name>, <string-name><surname>Mercker</surname> <given-names>M</given-names></string-name>, <string-name><surname>Kling</surname> <given-names>S</given-names></string-name>, <string-name><surname>Fath</surname> <given-names>M</given-names></string-name>, <string-name><surname>Warnken</surname> <given-names>U</given-names></string-name>, <string-name><surname>Schnölzer</surname> <given-names>M</given-names></string-name>, <string-name><surname>Holstein</surname> <given-names>TW</given-names></string-name>, <string-name><surname>Hartl</surname> <given-names>M</given-names></string-name>, <string-name><surname>Marciniak-Czochra</surname> <given-names>A</given-names></string-name>, <string-name><surname>Stetefeld</surname> <given-names>J</given-names></string-name>, <string-name><surname>Stöcker</surname> <given-names>W</given-names></string-name>, <string-name><surname>Özbek</surname> <given-names>S</given-names></string-name>. <article-title>The Wnt-specific astacin proteinase HAS-7 restricts head organizer formation in Hydra</article-title>. <source>BMC Biol</source>. <year>2021</year>;<volume>19</volume>(<issue>1</issue>):<fpage>120</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12915-021-01046-9</pub-id>.</mixed-citation></ref>
<ref id="c75"><mixed-citation publication-type="journal"><string-name><surname>Zurawa-Janicka</surname> <given-names>D</given-names></string-name>, <string-name><surname>Wenta</surname> <given-names>T</given-names></string-name>, <string-name><surname>Jarzab</surname> <given-names>M</given-names></string-name>, <string-name><surname>Skorko-Glonek</surname> <given-names>J</given-names></string-name>, <string-name><surname>Glaza</surname> <given-names>P</given-names></string-name>, <string-name><surname>Gieldon</surname> <given-names>A</given-names></string-name>, <string-name><surname>Ciarkowski</surname> <given-names>J</given-names></string-name>, <string-name><surname>Lipinska</surname> <given-names>B</given-names></string-name>. <article-title>Structural insights into the activation mechanisms of human HtrA serine proteases</article-title>. <source>Arch Biochem Biophys</source>. <year>2017</year>;<volume>621</volume>:<fpage>6</fpage>–<lpage>23</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.abb.2017.04.004</pub-id>.</mixed-citation></ref>
</ref-list>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.91864.2.sa2</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Mishina</surname>
<given-names>Yuji</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>University of Michigan</institution>
</institution-wrap>
<city>Ann Arbor</city>
<country>United States of America</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Exceptional</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Fundamental</kwd>
</kwd-group>
</front-stub>
<body>
<p>This <bold>fundamental</bold> work substantially advances our understanding of cell migration, especially in that of cranial neural crest. The additional evidence provided to support the conclusion is <bold>exceptional</bold>, with rigorous biochemical assays for materials used and with intensive genetic interventions. The work will be of broad interest to developmental biologists and cell biologists.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.91864.2.sa1</article-id>
<title-group>
<article-title>Reviewer #1 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>A novel serine protease and a inhibitor pair regulate cell migration in the neural crest.</p>
<p>Strengths:</p>
<p>The reproduction of classical cranial neural crest extirpations and their phenocopy by SerpinE2 morpholino are remarkable. Very scholarly written and data of the highest quality.</p>
<p>Weaknesses:</p>
<p>All were improved upon revision.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.91864.2.sa0</article-id>
<title-group>
<article-title>Reviewer #2 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>The authors conducted research on the role of SerpinE2 and HtrA1 in neural crest migration using Xenopus embryos. The data presented in this study was of high quality and supported the authors' conclusions. The discovery of the potential molecular connection between SerpinE2 and HtrA1 in neural crest cell migration in vivo is significant, as understanding this pathway could potentially lead to treatments for aggressive cancers and pregnancy-related disorders.</p>
<p>Strengths:</p>
<p>Previous research has shown that SerpinE2 and HtrA1 can have both positive and negative effects on cell migration, but their molecular interplay and role in neural crest migration are not well-established. This study is the first to reveal a potential connection between these two proteins in neural crest cell migration in vivo. The authors found that SerpinE2 promotes neural crest migration by inhibiting HtrA1. Additionally, overexpression of Sdc4 partly alleviates neural crest migration issues caused by SerpinE2 knockdown or HtrA1 overexpression. These findings suggest that the SeprinE2-HtrA1-Sdc4 pathway is crucial for neural crest migration.</p>
<p>Weaknesses:</p>
<p>To further increase the study's credibility, it may be helpful to use techniques like western blotting, qRT-PCR, or in situ hybridization to verify the efficiency of SerpinE2 and HtrA1 knockdown and/or overexpression.</p>
</body>
</sub-article>
<sub-article id="sa3" article-type="author-comment">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.91864.2.sa3</article-id>
<title-group>
<article-title>Author Response</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Pera</surname>
<given-names>Edgar M.</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0625-0006</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Moura</surname>
<given-names>Josefine Nilsson-De</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pomeshchik</surname>
<given-names>Yuriy</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1412-7403</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Roybon</surname>
<given-names>Laurent</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5532-4964</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Milas</surname>
<given-names>Ivana</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>The following is the authors’ response to the original reviews.</p>
<p>We thank the two reviewers for their very thoughtful suggestions and the editors for writing the eLife assessment. We will submit a revised manuscript that addresses most comments and include a point-by-point response to the reviewers. We will provide evidence that overexpression of the HtrA1 protease and knockdown of its inhibitor SerpinE2 reduce the development of neural crest-derived cartilage elements in the head of Xenopus embryos. This will be done by whole mount in situ hybridization, using a probe for the chondrogenic marker Sox9. We will also provide two time-lapse movies showing (1) collective migration of cranial neural crest cells in culture and (2) failure of these cells to adhere to fibronectin upon SerpinE2 depletion. We will discuss in more depth how the SerpinE2-HtrA1 proteolytic pathway and its target, the heparan sulfate proteoglycan Syndecan-4, might regulate FGF signaling and suggest a model, in which serpin secreted by the leader cells and the protease released by the follower cells might establish a chemotactic FGF gradient for the directed migration of the neural crest cohort. The criticism that other factors such as proliferation and cell survival might contribute to the observed craniofacial phenotypes upon misexpression of SerpinE2 and HtrA1, and that it remains unclear to what extent the mechanism reported here is conserved in the trunk neural crest is valid. The reason we focused on the more amenable cranial neural crest in the Xenopus embryo and used a multitude of approaches – structure-function studies, biochemical analyses, in vitro explant assays and epistatic experiments in vivo – was to validate a central finding: that an extracellular proteolytic pathway involving a serpin, a protease and a proteoglycan regulates by a double inhibition mechanism collective cell migration.</p>
</body>
</sub-article>
</article>